<?xml version='1.0' encoding='UTF-8'?>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4"><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Neurol</journal-id><journal-id journal-id-type="iso-abbrev">BMC Neurol</journal-id><journal-id journal-id-type="pmc-domain-id">48</journal-id><journal-id journal-id-type="pmc-domain">bmcneul</journal-id><journal-title-group><journal-title>BMC Neurology</journal-title></journal-title-group><issn pub-type="epub">1471-2377</issn><publisher><publisher-name>BMC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC6933911</article-id><article-id pub-id-type="pmcid-ver">PMC6933911.1</article-id><article-id pub-id-type="pmcaid">6933911</article-id><article-id pub-id-type="pmcaiid">6933911</article-id><article-id pub-id-type="pmid">31881858</article-id><article-id pub-id-type="doi">10.1186/s12883-019-1567-0</article-id><article-id pub-id-type="publisher-id">1567</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Multimodal MRI of grey matter, white matter, and functional connectivity in cognitively healthy mutation carriers at risk for frontotemporal dementia and Alzheimer's disease</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-4040-7900</contrib-id><name name-style="western"><surname>Feis</surname><given-names initials="RA">Rogier A.</given-names></name><address><email>r.a.feis@lumc.nl</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Bouts</surname><given-names initials="MJRJ">Mark J. R. J.</given-names></name><address><email>m.j.r.j.bouts@fsw.leidenuniv.nl</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff3">3</xref><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Dopper</surname><given-names initials="EGP">Elise G. P.</given-names></name><address><email>e.dopper@erasmusmc.nl</email></address><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Filippini</surname><given-names initials="N">Nicola</given-names></name><address><email>nicolaf@fmrib.ox.ac.uk</email></address><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff6">6</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Heise</surname><given-names initials="V">Verena</given-names></name><address><email>verena.heise@psych.ox.ac.uk</email></address><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff6">6</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Trachtenberg</surname><given-names initials="AJ">Aaron J.</given-names></name><address><email>aaron_trachtenberg@hotmail.com</email></address><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>van Swieten</surname><given-names initials="JC">John C.</given-names></name><address><email>j.c.vanswieten@erasmusmc.nl</email></address><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>van Buchem</surname><given-names initials="MA">Mark A.</given-names></name><address><email>m.a.van_buchem@lumc.nl</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>van der Grond</surname><given-names initials="J">Jeroen</given-names></name><address><email>j.van_der_grond@lumc.nl</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Mackay</surname><given-names initials="CE">Clare E.</given-names></name><address><email>clare.mackay@psych.ox.ac.uk</email></address><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff6">6</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Rombouts</surname><given-names initials="SARB">Serge A. R. B.</given-names></name><address><email>s.a.r.b.rombouts@lumc.nl</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff3">3</xref><xref ref-type="aff" rid="Aff4">4</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000000089452978</institution-id><institution-id institution-id-type="GRID">grid.10419.3d</institution-id><institution>Department of Radiology, </institution><institution>Leiden University Medical Centre, </institution></institution-wrap>Leiden, The Netherlands </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1936 8948</institution-id><institution-id institution-id-type="GRID">grid.4991.5</institution-id><institution>FMRIB, Oxford Centre for Functional Magnetic Resonance Imaging of the Brain, Nuffield Department of Clinical Neurosciences, </institution><institution>University of Oxford, </institution></institution-wrap>Oxford, UK </aff><aff id="Aff3"><label>3</label>LIBC, Leiden Institute for Brain and Cognition, Leiden, The Netherlands </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2312 1970</institution-id><institution-id institution-id-type="GRID">grid.5132.5</institution-id><institution>Institute of Psychology, </institution><institution>Leiden University, </institution></institution-wrap>Leiden, The Netherlands </aff><aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ISNI">000000040459992X</institution-id><institution-id institution-id-type="GRID">grid.5645.2</institution-id><institution>Department of Neurology, </institution><institution>Erasmus Medical Centre, </institution></institution-wrap>Rotterdam, The Netherlands </aff><aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1936 8948</institution-id><institution-id institution-id-type="GRID">grid.4991.5</institution-id><institution>Department of Psychiatry, </institution><institution>University of Oxford, </institution></institution-wrap>Oxford, UK </aff></contrib-group><pub-date pub-type="epub"><day>27</day><month>12</month><year>2019</year></pub-date><pub-date pub-type="collection"><year>2019</year></pub-date><volume>19</volume><issue-id pub-id-type="pmc-issue-id">326689</issue-id><elocation-id>343</elocation-id><history><date date-type="received"><day>18</day><month>10</month><year>2019</year></date><date date-type="accepted"><day>11</day><month>12</month><year>2019</year></date></history><pub-history><event event-type="pmc-release"><date><day>27</day><month>12</month><year>2019</year></date></event><event event-type="pmc-live"><date><day>30</day><month>12</month><year>2019</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-07-22 23:25:26.820"><day>22</day><month>07</month><year>2024</year></date></event></pub-history><permissions><copyright-statement>© The Author(s). 2019</copyright-statement><license license-type="OpenAccess"><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="12883_2019_Article_1567.pdf"/><abstract id="Abs1"><sec><title>Background</title><p id="Par1">Frontotemporal dementia (FTD) and Alzheimer’s disease (AD) are associated with divergent differences in grey matter volume, white matter diffusion, and functional connectivity. However, it is unknown at what disease stage these differences emerge. Here, we investigate whether divergent differences in grey matter volume, white matter diffusion, and functional connectivity are already apparent between cognitively healthy carriers of pathogenic FTD mutations, and cognitively healthy carriers at increased AD risk.</p></sec><sec><title>Methods</title><p id="Par2">We acquired multimodal magnetic resonance imaging (MRI) brain scans in cognitively healthy subjects with (<italic toggle="yes">n</italic>=39) and without (<italic toggle="yes">n</italic>=36) <italic toggle="yes">microtubule-associated protein Tau</italic> (<italic toggle="yes">MAPT</italic>) or <italic toggle="yes">progranulin</italic> (<italic toggle="yes">GRN</italic>) mutations, and with (<italic toggle="yes">n</italic>=37) and without (<italic toggle="yes">n</italic>=38) <italic toggle="yes">apolipoprotein E ε4</italic> (<italic toggle="yes">APOE4</italic>) allele. We evaluated grey matter volume using voxel-based morphometry, white matter diffusion using tract-based spatial statistics (TBSS), and region-to-network functional connectivity using dual regression in the default mode network and salience network. We tested for differences between the respective carriers and controls, as well as for divergence of those differences. For the divergence contrast, we additionally performed region-of-interest TBSS analyses in known areas of white matter diffusion differences between FTD and AD (i.e., uncinate fasciculus, forceps minor, and anterior thalamic radiation).</p></sec><sec><title>Results</title><p id="Par3"><italic toggle="yes">MAPT/GRN</italic> carriers did not differ from controls in any modality. <italic toggle="yes">APOE4</italic> carriers had lower fractional anisotropy than controls in the callosal splenium and right inferior fronto-occipital fasciculus, but did not show grey matter volume or functional connectivity differences. We found no divergent differences between both carrier-control contrasts in any modality, even in region-of-interest analyses.</p></sec><sec><title>Conclusions</title><p id="Par4">Concluding, we could not find differences suggestive of divergent pathways of underlying FTD and AD pathology in asymptomatic risk mutation carriers. Future studies should focus on asymptomatic mutation carriers that are closer to symptom onset to capture the first specific signs that may differentiate between FTD and AD.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Microtubule-associated protein tau</kwd><kwd>progranulin</kwd><kwd>Apolipoprotein E4</kwd><kwd>Voxel-based morphometry (VBM)</kwd><kwd>diffusion tensor imaging (DTI)</kwd><kwd>Tract-based spatial statistics (TBSS)</kwd><kwd>functional connectivity</kwd><kwd>Dual Regression Analysis</kwd><kwd>Frontotemporal dementia</kwd><kwd>Alzheimer’s disease</kwd></kwd-group><funding-group><award-group><funding-source><institution>Leiden University Medical Center</institution></funding-source><award-id>MD/PhD Scholarship</award-id><principal-award-recipient><name name-style="western"><surname>Feis</surname><given-names>Rogier A.</given-names></name></principal-award-recipient></award-group></funding-group><funding-group><award-group><funding-source><institution>HDH Wills 1965 charitable trusts</institution></funding-source><award-id>English Charity Register 1117747</award-id><principal-award-recipient><name name-style="western"><surname>Filippini</surname><given-names>Nicola</given-names></name></principal-award-recipient></award-group></funding-group><funding-group><award-group><funding-source><institution>Alzheimer's Research UK</institution></funding-source><award-id>English Charity Register 1077089</award-id><principal-award-recipient><name name-style="western"><surname>Heise</surname><given-names>Verena</given-names></name></principal-award-recipient></award-group></funding-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000697</institution-id><institution>Rhodes Scholarships</institution></institution-wrap></funding-source></award-group></funding-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001826</institution-id><institution>ZonMw</institution></institution-wrap></funding-source><award-id>Memorabel project 733050103</award-id></award-group></funding-group><funding-group><award-group><funding-source><institution>JPND</institution></funding-source><award-id>PreFrontAls consortium project 733051042</award-id></award-group></funding-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100013373</institution-id><institution>NIHR Oxford Biomedical Research Centre</institution></institution-wrap></funding-source></award-group></funding-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100003246</institution-id><institution>Nederlandse Organisatie voor Wetenschappelijk Onderzoek</institution></institution-wrap></funding-source><award-id>016130667</award-id><principal-award-recipient><name name-style="western"><surname>Rombouts</surname><given-names>Serge A. R. B.</given-names></name></principal-award-recipient></award-group></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-license-ref</meta-name><meta-value>CC BY</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>© The Author(s) 2019</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Background</title><p id="Par21">Frontotemporal dementia (FTD) and Alzheimer’s disease (AD) are two of the most common causes of dementia [<xref ref-type="bibr" rid="CR1">1</xref>–<xref ref-type="bibr" rid="CR4">4</xref>]. In addition to distinct clinical features [<xref ref-type="bibr" rid="CR5">5</xref>–<xref ref-type="bibr" rid="CR9">9</xref>], FTD and AD demonstrate different patterns of functional and structural neurodegeneration on magnetic resonance imaging (MRI) [<xref ref-type="bibr" rid="CR10">10</xref>–<xref ref-type="bibr" rid="CR17">17</xref>]. Atrophy is more pronounced in FTD than in AD in frontotemporal areas such as the anterior cingulate cortex, fronto-insula, and inferior frontal cortex [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR15">15</xref>]. Conversely, AD patients have more atrophy in the occipital gyrus and precuneus than FTD patients [<xref ref-type="bibr" rid="CR13">13</xref>]. In terms of white matter diffusion tensor imaging (DTI) alterations, FTD patients have reduced fractional anisotropy (FA) and increased radial diffusivity (RD) compared to AD patients in the uncinate fasciculi, forceps minor, and anterior thalamic radiation, whereas AD patients do not show FA decreases or RD increases compared to FTD patients [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR13">13</xref>–<xref ref-type="bibr" rid="CR16">16</xref>]. Furthermore, functional connectivity is inversely affected in FTD and AD. In FTD patients, functional connectivity with the salience network is disrupted, while functional connectivity with the default mode network is increased. Vice versa, functional connectivity with the default mode network is disrupted in AD patients, while functional connectivity with the salience network is increased [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR17">17</xref>].</p><p id="Par22">Despite these different patterns of neurodegeneration, the differentiation between FTD and AD is often demanding when patients first present in the memory clinic. For example, FTD patients may first present with memory deficits [<xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR19">19</xref>], and as such may be misdiagnosed as AD patients. Conversely, AD patients may be misdiagnosed as FTD patients due to the presentation of behavioural symptoms [<xref ref-type="bibr" rid="CR20">20</xref>]. Indeed, 13% of initial FTD diagnoses were corrected to AD after two years follow-up [<xref ref-type="bibr" rid="CR21">21</xref>], while 10–30% of clinical FTD patients were found to have AD pathology upon autopsy [<xref ref-type="bibr" rid="CR22">22</xref>–<xref ref-type="bibr" rid="CR24">24</xref>].The current criteria for behavioural variant FTD (bvFTD) [<xref ref-type="bibr" rid="CR5">5</xref>], and language FTD variants [<xref ref-type="bibr" rid="CR6">6</xref>] lack specificity to distinguish early-stage FTD patients from early-stage AD patients [<xref ref-type="bibr" rid="CR7">7</xref>]. This diagnostic problem delays effective disease management [<xref ref-type="bibr" rid="CR21">21</xref>, <xref ref-type="bibr" rid="CR25">25</xref>–<xref ref-type="bibr" rid="CR27">27</xref>], and frustrates the development of new treatments. Considering that the potential of disease-modifying drugs is highest in the stage before atrophy occurs, the identification of early-stage dementia patients is crucial for patient selection in clinical trials [<xref ref-type="bibr" rid="CR28">28</xref>].</p><p id="Par23">To assess whether FTD- and AD-related pathological changes are present even before symptom onset, carriers of FTD and AD risk mutations have been studied using structural, diffusion-weighted, and functional MRI (fMRI). For example, mutations in <italic toggle="yes">microtubule-associated protein Tau</italic> (<italic toggle="yes">MAPT</italic>), <italic toggle="yes">progranulin</italic> (<italic toggle="yes">GRN</italic>), and repeat expansions in <italic toggle="yes">chromosome 9 open reading frame 72</italic> (<italic toggle="yes">C9orf72</italic>) are known causes of genetic FTD. Presymptomatic carriers of these mutations have therefore been regularly used to investigate early-stage FTD-related pathology [<xref ref-type="bibr" rid="CR29">29</xref>–<xref ref-type="bibr" rid="CR33">33</xref>]. Similarly, mutations in <italic toggle="yes">presenilin 1</italic>, <italic toggle="yes">presenilin 2</italic>, and <italic toggle="yes">amyloid precursor protein</italic> are known causes of genetic AD. However, due to its higher prevalence, <italic toggle="yes">apolipoprotein E ε4</italic> (<italic toggle="yes">APOE4</italic>), the strongest risk factor for sporadic AD, has been more extensively used to study early-stage AD-related pathology [<xref ref-type="bibr" rid="CR34">34</xref>–<xref ref-type="bibr" rid="CR43">43</xref>].</p><p id="Par24">Contrary to findings in clinical FTD and AD [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR13">13</xref>–<xref ref-type="bibr" rid="CR16">16</xref>], differences in diffusion metrics associated with asymptomatic <italic toggle="yes">APOE4</italic> [<xref ref-type="bibr" rid="CR39">39</xref>, <xref ref-type="bibr" rid="CR44">44</xref>–<xref ref-type="bibr" rid="CR51">51</xref>] are more widespread than diffusion differences associated with asymptomatic <italic toggle="yes">MAPT/GRN</italic> mutation carriers [<xref ref-type="bibr" rid="CR32">32</xref>, <xref ref-type="bibr" rid="CR33">33</xref>]. Functional connectivity differences have also been shown in these asymptomatic groups [<xref ref-type="bibr" rid="CR32">32</xref>, <xref ref-type="bibr" rid="CR41">41</xref>]. However, a comparison between these presymptomatic patterns of change in risk mutation carriers for FTD and AD is lacking, even though early-stage differences between these dementias may aid early differential diagnosis.</p><p id="Par25">To this end, we investigated multimodal MRI in asymptomatic subjects at risk for FTD and AD. First, we aimed to replicate early carrier-control differences found between <italic toggle="yes">MAPT</italic>/<italic toggle="yes">GRN</italic> mutation carriers and controls, and between <italic toggle="yes">APOE4</italic> carriers and controls, respectively, by assessing whole-brain grey matter volume, white matter DTI measures, and functional connectivity in the default mode network and salience network. Secondly, we investigated whether <italic toggle="yes">MAPT/GRN</italic> carrier-control differences diverged from <italic toggle="yes">APOE4</italic> carrier-control differences, similar to FTD-AD differences. For the latter analysis, we additionally evaluated a priori selected white matter tracts known to be affected more strongly in FTD than AD (i.e., uncinate fasciculus, forceps minor, and anterior thalamic radiation). We hypothesised that the differences in grey matter volumes, DTI measures, and functional connectivity seen in FTD and AD patients [<xref ref-type="bibr" rid="CR10">10</xref>–<xref ref-type="bibr" rid="CR17">17</xref>] may also be present to a smaller extent before symptom-onset in risk mutation carriers.</p></sec><sec id="Sec2"><title>Materials and methods</title><sec id="Sec3"><title>Participants</title><p id="Par26">Subjects were included retrospectively from studies carried out at the Leiden University Medical Centre (LUMC), The Netherlands, and at the Functional Magnetic Resonance Imaging of the Brain Centre (FMRIB), Oxford, UK.</p><p id="Par27">The Dutch sample included 39 <italic toggle="yes">MAPT/GRN</italic> mutation carriers (11 <italic toggle="yes">MAPT</italic>, 28 <italic toggle="yes">GRN</italic>) and 36 controls, recruited from a pool of 160 healthy first-degree relatives of FTD patients with either <italic toggle="yes">MAPT</italic> or <italic toggle="yes">GRN</italic> mutation [<xref ref-type="bibr" rid="CR32">32</xref>]. Participants were considered asymptomatic in the absence of (1) behavioural, cognitive, or neuropsychiatric change reported by the participant or knowledgeable informant, (2) cognitive disorders on neuropsychiatric tests, (3) motor neuron disease signs on neurologic examination, and (4) other FTD [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR6">6</xref>] or amyotrophic lateral sclerosis [<xref ref-type="bibr" rid="CR52">52</xref>] criteria. Asymptomatic non-carriers from these families and the general population were assumed to have equal risk of developing dementia. <italic toggle="yes">MAPT/GRN</italic> mutation carriers and controls were not tested for <italic toggle="yes">APOE4</italic> alleles.</p><p id="Par28">Data from 37 <italic toggle="yes">APOE4</italic> carriers (30 <italic toggle="yes">apolipoprotein E ε3/ε4</italic> heterozygotes, 7 <italic toggle="yes">apolipoprotein E ε4/ε4</italic> homozygotes) and 38 controls (all <italic toggle="yes">apolipoprotein E ε3/ε3</italic> homozygotes) were collected in Oxford from the general population in Oxfordshire and were selected to match the Dutch sample in terms of age and gender. Due to the limited sample size, it was not possible to match the groups' education level. Middle-aged and elderly <italic toggle="yes">APOE4</italic> carriers and controls underwent a pre-screening cognitive test (Addenbrooke's Cognitive Examination-revised version [<xref ref-type="bibr" rid="CR39">39</xref>, <xref ref-type="bibr" rid="CR40">40</xref>]) to assure asymptomatic status. <italic toggle="yes">APOE4</italic> carriers and controls were not tested for <italic toggle="yes">MAPT/GRN</italic> mutations.</p><p id="Par29">In both cohorts, participants were between 21 and 70 years old. A priori exclusion criteria included MRI contraindications, head injury, current or past neurologic or psychiatric disorders, (history of) substance abuse including alcohol, corticosteroid therapy, type I diabetes therapy, and memory complaints.</p><p id="Par30">The study was conducted in accordance with regional regulations and the Declaration of Helsinki. Written informed consent was received from all participants, and ethical approval for data acquisition was provided by the Medical Ethical Committees in Rotterdam and Leiden for <italic toggle="yes">MAPT/GRN</italic> data, and the National Research Ethics Service Committee South Central – Oxford C for <italic toggle="yes">APOE4</italic> data. For further details regarding the recruitment protocols, see Dopper et al. (2014) [<xref ref-type="bibr" rid="CR32">32</xref>] for the Dutch sample and Filippini et al. (2011) [<xref ref-type="bibr" rid="CR40">40</xref>] for the English sample.</p></sec><sec id="Sec4"><title>Image acquisition</title><p id="Par31">MRI data were acquired with a Philips 3 T Achieva MRI scanner using an 8-channel SENSE head coil (<italic toggle="yes">MAPT/GRN</italic> mutation carriers and controls) or on a Siemens 3 T Trio scanner with a 12-channel head coil (<italic toggle="yes">APOE4</italic> carriers and controls). T1-weighted data were acquired with TR=9.8 ms, TE=4.6 ms, flip angle=8°, 140 axial slices, and voxel size is 0.88 x 0.88 x 1.20 mm for <italic toggle="yes">MAPT/GRN</italic> mutation carriers and controls, and using a magnetisation-prepared rapid gradient echo sequence (MPRAGE; TR=2040 ms, TE=4.7 ms, flip angle=8°, 192 axial slices, voxel size is 1 x 1 x 1 mm) in <italic toggle="yes">APOE4</italic> carriers and controls. Diffusion-weighted images were acquired in 62 directions with TR=8250-9300 ms, TE=80-94 ms, b-value=1000 s/mm<sup>2</sup>, flip angle=90°, 65-70 axial slices, and voxel size is 2 x 2 x 2 mm. For the resting-state functional MRI (rs-fMRI) scan, subjects were instructed to remain awake and keep their eyes closed (<italic toggle="yes">MAPT/GRN</italic> mutation carriers and controls) or open (<italic toggle="yes">APOE4</italic> carriers and controls), and to think of nothing in particular. We acquired 180-200 volumes with TR=2000-2200 ms, TE=28-30 ms, flip angle=80-89°, and voxel size is 2.75 x 2.75 x 2.75 mm + 10% interslice gap or 3 x 3 x 3.5 mm.</p></sec><sec id="Sec5"><title>Image analysis</title><p id="Par32">FMRIB’s Software Library (FSL, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.fmrib.ox.ac.uk/fsl"><underline>http://www.fmrib.ox.ac.uk/fsl</underline></ext-link>) tools were used for all data analyses [<xref ref-type="bibr" rid="CR53">53</xref>].</p><sec id="Sec6"><title>Grey matter volume analyses</title><p id="Par33">Whole-brain voxel-wise structural analysis was carried out with FSL-VBM [<xref ref-type="bibr" rid="CR54">54</xref>], an optimised voxel-based morphometry protocol [<xref ref-type="bibr" rid="CR55">55</xref>] using FSL tools [<xref ref-type="bibr" rid="CR56">56</xref>]. First, we performed brain extraction and grey matter segmentation, and registered images to the MNI-152 standard space using linear (FLIRT) and non-linear registration (FNIRT [<xref ref-type="bibr" rid="CR57">57</xref>]). The resulting images were averaged and flipped along the x-axis to create a study-specific grey matter template. Native grey matter images were then re-registered to this template, modulated using the field-warp Jacobian, and smoothed using an isotropic Gaussian kernel with a sigma of 2.5 mm (~ 6 mm full width at half maximum).</p></sec><sec id="Sec7"><title>Diffusion tensor imaging</title><p id="Par34">Diffusion-weighted imaging scans were processed using FMRIB’s Diffusion Toolbox (FDT, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.fmrib.ox.ac.uk/fsl/fdt">http://www.fmrib.ox.ac.uk/fsl/fdt</ext-link>). First, we aligned raw diffusion weighted images to the b0-volume using “eddy correct” to correct for movement and eddy currents. Next, we fitted the diffusion tensor model to the images at each voxel to create modality-specific images for fractional anisotropy (FA), mean diffusivity (MD), axial diffusivity (AxD), and radial diffusivity (RD). For voxel-wise analysis of these images, we used tract-based spatial statistics [<xref ref-type="bibr" rid="CR58">58</xref>]. After brain extraction, subjects’ individual FA images were transformed to standard space using FNIRT. A mean FA image then was created and thinned to generate a whole-brain mean FA skeleton, representing the centres of all white matter tracts common to all subjects. Individual aligned FA images were projected onto this skeleton for group analysis. Similar analyses were performed on MD, AxD, and RD maps using the spatial transformation parameters that were estimated in the FA analysis. For our region-of-interest analyses, we masked the whole-brain skeleton with the combined masks of the uncinate fasciculi, forceps minor, and the bilateral anterior thalamic radiations, which have been shown to differ between FTD and AD patients in terms of DTI metrics [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR13">13</xref>–<xref ref-type="bibr" rid="CR16">16</xref>].</p></sec><sec id="Sec8"><title>Resting-state functional MRI</title><p id="Par35">Pre-statistical processing of resting-state data consisted of motion correction [<xref ref-type="bibr" rid="CR59">59</xref>], brain extraction, spatial smoothing using a Gaussian kernel of 6 mm full width at half maximum, 4D grand-mean scaling and high-pass temporal filtering corresponding to a period of 150s (~ 0.007 Hz). Registration to MNI-152 standard space was carried out in two steps. We registered echo-planar images onto their respective T1-weighted structural images using FLIRT and Boundary-Based Registration [<xref ref-type="bibr" rid="CR59">59</xref>–<xref ref-type="bibr" rid="CR61">61</xref>]. Next, we used FNIRT to align T1-weighted structural images to MNI-152 standard space, and concatenated the resulting registration matrices to register echo-planar images directly to standard space. Next, we performed individual Independent Component Analysis (ICA) and voxel-wise intensity normalisation (i.e., by dividing all voxels by their time series’ mean values and multiplying by 10,000).</p><p id="Par36">We used FMRIB’s ICA-based X-noiseifier (FIX [<xref ref-type="bibr" rid="CR62">62</xref>–<xref ref-type="bibr" rid="CR64">64</xref>]) to clean up noise components and reduce rs-fMRI scan site bias. For a detailed description and validation of FIX as a multicentre bias reduction method, see Feis et al. (2015) [<xref ref-type="bibr" rid="CR64">64</xref>]. In short, we classified the individual ICA components of a subset of the subjects as signal, noise or unknown, trained the FIX classifier, and used a leave-one-out test to control the algorithm’s quality. All subjects’ data were then classified using the optimal threshold (i.e., 20 – true-positive rate 95.1%, true-negative rate 91.4%) and structured noise components were removed.</p><p id="Par37">After processing and application of FIX, rs-fMRI data were temporally concatenated and decomposed into 25 components using FSL’s group-level ICA tool [<xref ref-type="bibr" rid="CR65">65</xref>–<xref ref-type="bibr" rid="CR67">67</xref>], in order to identify large-scale patterns of functional connectivity. The resulting group-level ICA spatial maps were compared to previously described resting-state networks [<xref ref-type="bibr" rid="CR67">67</xref>–<xref ref-type="bibr" rid="CR71">71</xref>], and we selected default mode network components and salience network components for dual regression analyses. The default mode network is disrupted in AD, and enhanced in FTD, while the salience network is disrupted in FTD and enhanced in AD [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR17">17</xref>]. Components that included the precuneus, posterior cingulate cortex, angular gyrus, medial pre-frontal cortex and hippocampus were regarded as parts of the default mode network. Components featuring the anterior cingulate cortex, supplementary motor area and insula were considered linked to the salience network. We found three networks resembling the default mode network (e.g., the anterior, inferior and posterior default mode network, Fig. <xref rid="Fig1" ref-type="fig">1</xref>a-c) and two networks resembling the salience network (e.g., the anterior and posterior salience network, Fig. <xref rid="Fig1" ref-type="fig">1</xref>d-e). For these five resulting resting-state networks of interest, we performed dual regression to identify the subject-specific spatial maps corresponding to the resting-state networks of interest [<xref ref-type="bibr" rid="CR37">37</xref>, <xref ref-type="bibr" rid="CR72">72</xref>]. First, the spatial maps derived from group-level ICA were used as a spatial regressor in each subjects’ rs-fMRI data to obtain subject-specific time series describing the temporal dynamics for each component (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S1, step 1). Next, the time series found by spatial regression were used as a temporal regressor to find the voxels associated with those time series for each subject (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S1, step 2). As such, we used the group-level ICA networks of interest to obtain subject-specific spatial maps that allow for voxel-wise comparison. Statistical analysis of region-to-network functional connectivity group differences was then carried out by testing for the functional connectivity between the five resting-state networks of interest and all other grey matter voxels.
<fig id="Fig1" position="float" orientation="portrait"><label>Fig. 1</label><caption><p>Resting-state networks. Maps illustrate the most informative slices of resting-state networks of interest that featured known default mode network and salience network regions and that were used for statistical testing after dual regression</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO1" position="float" orientation="portrait" xlink:href="12883_2019_1567_Fig1_HTML.jpg"/></fig></p></sec></sec><sec id="Sec9"><title>Statistical analysis</title><p id="Par38">Statistical analysis of grey matter volume, DTI features, and rs-fMRI data was performed using general linear models, including age and education as confound regressors. Additionally, we added a voxel-wise covariate for grey matter volume to the functional connectivity analyses. We tested for differences between, respectively, <italic toggle="yes">MAPT/GRN</italic> mutation carriers and controls, and differences between <italic toggle="yes">APOE4</italic> carriers and controls. Additionally, we tested for the differences between these respective carrier-control contrasts to evaluate whether these gene mutations have divergent effects on the brain in cognitively healthy carriers that might reflect early substrates of FTD or AD pathology. Since possible centre effects are equivalent for carriers and controls at each site, these effects cancel out when we compared the carrier-control effect at one site to the carrier-control effect at the other site. Consequently, unknown confounding factors such as scanner and population differences should have minimal influence on our results.</p><p id="Par39">Pooling <italic toggle="yes">MAPT</italic> and <italic toggle="yes">GRN</italic> mutation carriers, and <italic toggle="yes">APOE4</italic> heterozygotes and homozygotes in our carrier samples may have increased heterogeneity in our groups. To account for this possibility, we performed additional analyses with covariates encoding the difference between <italic toggle="yes">MAPT</italic> and <italic toggle="yes">GRN</italic> mutations, and between <italic toggle="yes">APOE4</italic> hetero- and homozygosity.</p><p id="Par40">Voxel-wise application of these general linear models to the data was performed using FSL randomise, a permutation-based non-parametric test (5,000 permutations). We set the family-wise error rate at 5% across space by using threshold-free cluster enhancement [<xref ref-type="bibr" rid="CR73">73</xref>] in all analyses. The alpha level required for statistical significance was set at 0.025 for all imaging analyses, which corresponds to an alpha level of 0.05 in a two-sided <italic toggle="yes">t</italic>-test, since randomise performs the permutation equivalent of a one-sided <italic toggle="yes">t</italic>-test. Minimal cluster size for significant results was set at 10 voxels.</p><p id="Par41">SPSS version 24 (SPSS, Chicago, IL) was used for statistics performed on non-imaging (demographic) variables. Analysis of variance (ANOVA) tests were performed on normally distributed continuous variables (age and education) and included Bonferroni post-hoc tests. A <italic toggle="yes">χ</italic><sup>2</sup> test was performed for gender. The alpha level required for statistical significance was set at 0.05.</p></sec></sec><sec id="Sec10"><title>Results</title><sec id="Sec11"><title>Demographics</title><p id="Par42">Demographic data for all groups are shown in Table <xref rid="Tab1" ref-type="table">1</xref>. Age and gender did not differ between groups. Bonferroni post-hoc tests revealed significantly lower education level in years for <italic toggle="yes">MAPT/GRN</italic> mutation carriers than <italic toggle="yes">APOE4</italic> controls (<italic toggle="yes">p</italic>=0.001), for <italic toggle="yes">MAPT/GRN</italic> controls than <italic toggle="yes">APOE4</italic> controls (<italic toggle="yes">p</italic>&lt;0.001), and for <italic toggle="yes">MAPT/GRN</italic> controls than <italic toggle="yes">APOE4</italic> carriers (<italic toggle="yes">p</italic>=0.001).
<table-wrap id="Tab1" position="float" orientation="portrait"><label>Table 1</label><caption><p>Participant demographics</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" colspan="1"/><th colspan="2" rowspan="1"><italic toggle="yes">MAPT/GRN</italic></th><th colspan="2" rowspan="1"><italic toggle="yes">APOE4</italic></th><th rowspan="2" colspan="1"><italic toggle="yes">P</italic>-value</th></tr><tr><th colspan="1" rowspan="1">Carriers (<italic toggle="yes">n</italic>=39)<sup>a</sup></th><th colspan="1" rowspan="1">Controls (<italic toggle="yes">n</italic>=36)</th><th colspan="1" rowspan="1">Carriers (<italic toggle="yes">n</italic>=37)<sup>b</sup></th><th colspan="1" rowspan="1">Controls (<italic toggle="yes">n</italic>=38)</th></tr></thead><tbody><tr><td colspan="1" rowspan="1">Age, y<sup>c</sup></td><td colspan="1" rowspan="1">50.5 (10.0)</td><td colspan="1" rowspan="1">49.8 (11.3)</td><td colspan="1" rowspan="1">48.6 (10.3)</td><td colspan="1" rowspan="1">50.5 (10.5)</td><td colspan="1" rowspan="1">0.855</td></tr><tr><td colspan="1" rowspan="1">Gender, % Female</td><td colspan="1" rowspan="1">23 (59%)</td><td colspan="1" rowspan="1">18 (50%)</td><td colspan="1" rowspan="1">20 (54%)</td><td colspan="1" rowspan="1">20 (53%)</td><td colspan="1" rowspan="1">0.885</td></tr><tr><td colspan="1" rowspan="1">Education, y<sup>c</sup></td><td colspan="1" rowspan="1">14.0 (2.5)</td><td colspan="1" rowspan="1">12.6 (2.9)</td><td colspan="1" rowspan="1">15.5 (3.7)</td><td colspan="1" rowspan="1">16.8 (3.2)</td><td colspan="1" rowspan="1">&lt; 0.001*</td></tr></tbody></table><table-wrap-foot><p><italic toggle="yes">APOE4, Apolipoprotein E ε4</italic> carriers; <italic toggle="yes">MAPT/GRN, Microtubule-associated protein Tau / progranulin</italic> carriers.</p><p><sup>a</sup>11 <italic toggle="yes">MAPT</italic> 28 <italic toggle="yes">GRN</italic>.</p><p><sup>b</sup>30 heterozygotes, 7 homozygotes.</p><p><sup>c</sup>Values denote mean (SD); education values were missing for three MAPT/GRN carriers and two <italic toggle="yes">MAPT/GRN</italic> controls.</p><p>*statistically significant at <italic toggle="yes">p</italic> &lt; 0.05.</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec12"><title>Grey matter volume</title><p id="Par43">We found no grey matter volume differences in <italic toggle="yes">MAPT/GRN</italic> mutation carriers compared to controls or <italic toggle="yes">APOE4</italic> carriers and compared to controls, nor were there differences between both contrasts.</p></sec><sec id="Sec13"><title>White matter diffusion</title><p id="Par44">Tract-based spatial statistics revealed no FA, MD, AxD, or RD differences between <italic toggle="yes">MAPT/GRN</italic> mutation carriers and controls. However, we found four clusters of FA reductions in <italic toggle="yes">APOE4</italic> carriers compared to controls (Fig. <xref rid="Fig2" ref-type="fig">2</xref>, Table <xref rid="Tab2" ref-type="table">2</xref>). Three clusters were located in the forceps major, more specifically in right side of the callosal splenium, and one cluster was located in the right inferior fronto-occipital fasciculus. We found no significant differences between the <italic toggle="yes">MAPT/GRN</italic> and <italic toggle="yes">APOE4</italic> carrier-control contrasts in our whole-brain analysis, nor in our region-of-interest analyses.
<fig id="Fig2" position="float" orientation="portrait"><label>Fig. 2</label><caption><p>White matter FA analysis. Differences in FA (or lack thereof) are shown for each contrast (e.g., <italic toggle="yes">MAPT/GRN</italic> mutation carriers greater or smaller than controls; <italic toggle="yes">APOE4</italic> carriers greater or smaller than controls; <italic toggle="yes">MAPT/GRN</italic> carrier-control differences greater or smaller than <italic toggle="yes">APOE4</italic> carrier-control differences). Mean skeleton maps are shown in green; skeletonised significant results were thickened for better visualisation. Four clusters of FA reductions were found in <italic toggle="yes">APOE4</italic> carriers compared to controls (middle left panel). Colour bar represents significance. <italic toggle="yes">APOE4, apolipoprotein E ε4</italic>; FA, fractional anisotropy; <italic toggle="yes">MAPT/GRN</italic>, <italic toggle="yes">microtubule-associated protein tau / progranulin</italic></p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO2" position="float" orientation="portrait" xlink:href="12883_2019_1567_Fig2_HTML.jpg"/></fig>
<table-wrap id="Tab2" position="float" orientation="portrait"><label>Table 2</label><caption><p>Cluster information</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" colspan="1">Cluster</th><th rowspan="2" colspan="1">Size</th><th rowspan="2" colspan="1">Max <italic toggle="yes">t</italic>-statistic</th><th colspan="3" rowspan="1">MNI coordinates</th><th rowspan="2" colspan="1">L/R</th><th rowspan="2" colspan="1">Area (peak voxel)</th></tr><tr><th colspan="1" rowspan="1">x</th><th colspan="1" rowspan="1">y</th><th colspan="1" rowspan="1">z</th></tr></thead><tbody><tr><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">64</td><td colspan="1" rowspan="1">4.14</td><td colspan="1" rowspan="1">54</td><td colspan="1" rowspan="1">101</td><td colspan="1" rowspan="1">72</td><td colspan="1" rowspan="1">R</td><td colspan="1" rowspan="1">IFOF</td></tr><tr><td colspan="1" rowspan="1">2</td><td colspan="1" rowspan="1">44</td><td colspan="1" rowspan="1">3.19</td><td colspan="1" rowspan="1">71</td><td colspan="1" rowspan="1">79</td><td colspan="1" rowspan="1">95</td><td colspan="1" rowspan="1">R</td><td colspan="1" rowspan="1">Splenium</td></tr><tr><td colspan="1" rowspan="1">3</td><td colspan="1" rowspan="1">32</td><td colspan="1" rowspan="1">3.58</td><td colspan="1" rowspan="1">63</td><td colspan="1" rowspan="1">73</td><td colspan="1" rowspan="1">87</td><td colspan="1" rowspan="1">R</td><td colspan="1" rowspan="1">Splenium</td></tr><tr><td colspan="1" rowspan="1">4</td><td colspan="1" rowspan="1">22</td><td colspan="1" rowspan="1">4.19</td><td colspan="1" rowspan="1">74</td><td colspan="1" rowspan="1">87</td><td colspan="1" rowspan="1">98</td><td colspan="1" rowspan="1">R</td><td colspan="1" rowspan="1">Splenium</td></tr></tbody></table><table-wrap-foot><p>Cluster information for significant clusters of reduced FA in <italic toggle="yes">APOE4</italic> carriers compared to controls. Minimum cluster size was 10.</p><p><italic toggle="yes">APOE4, Apolipoprotein E ε4</italic> carriers; IFOF, Inferior fronto-occipital fasciculus</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec14"><title>Functional connectivity</title><p id="Par45">We found no differences in region-to-network functional connectivity in <italic toggle="yes">MAPT/GRN</italic> mutation carriers compared to controls, in <italic toggle="yes">APOE4</italic> carriers compared to controls, or between the two carrier-control contrasts in any of the five resting-state networks.</p></sec><sec id="Sec15"><title>Heterogeneity analyses</title><p id="Par46">Analyses including covariates for the difference between <italic toggle="yes">MAPT</italic> and <italic toggle="yes">GRN</italic> mutations, and between <italic toggle="yes">APOE4</italic> hetero- and homozygosity yielded similar results as our main analyses. There were no grey matter volume differences between <italic toggle="yes">MAPT/GRN</italic> mutation carriers and controls, <italic toggle="yes">APOE4</italic> carriers and controls, or between the two carrier-control contrasts. <italic toggle="yes">APOE4</italic> carriers had reduced FA in compared to controls (Additional file <xref rid="MOESM2" ref-type="media">2</xref>: Figure S2), though only one of the four clusters remained significant. We found no DTI differences between <italic toggle="yes">MAPT/GRN</italic> mutation carriers and controls, nor between the two carrier-control contrasts. We found no differences in region-to-network functional connectivity in <italic toggle="yes">MAPT/GRN</italic> mutation carriers compared to controls, <italic toggle="yes">APOE4</italic> carriers compared to controls, or between the carrier-control contrasts in any of the five resting-state networks.</p></sec><sec id="Sec16" sec-type="data-availability"><title>Data availability</title><p id="Par47">All non-thresholded statistical images for grey matter volume, white matter diffusion, and functional connectivity results of our default analysis can be found on NeuroVault [<xref ref-type="bibr" rid="CR74">74</xref>]: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://neurovault.org/collections/NXLXKVCZ/">https://neurovault.org/collections/NXLXKVCZ/</ext-link>.</p></sec></sec><sec id="Sec17"><title>Discussion</title><p id="Par48">Differences in atrophy, white matter diffusion, and functional connectivity patterns have been repeatedly shown between FTD and AD patients [<xref ref-type="bibr" rid="CR11">11</xref>–<xref ref-type="bibr" rid="CR16">16</xref>], and between asymptomatic mutation carriers at risk for these diseases and controls (e.g., <italic toggle="yes">MAPT</italic> and <italic toggle="yes">GRN</italic> mutation carriers [<xref ref-type="bibr" rid="CR29">29</xref>–<xref ref-type="bibr" rid="CR33">33</xref>]; <italic toggle="yes">APOE4</italic> carriers [<xref ref-type="bibr" rid="CR34">34</xref>–<xref ref-type="bibr" rid="CR43">43</xref>]). However, comparisons between groups at risk for FTD and groups at risk for AD have been lacking, even though early-stage differences between these dementias are key to improve on diagnostic standards. In this study, we aimed to replicate previously found differences in asymptomatic mutation carriers at risk for FTD and AD compared to their respective control groups. More importantly, we investigated whether carrier-control differences diverged, similar to the divergences that exist between FTD and AD. While we could replicate some of the previously reported fractional anisotropy reductions in asymptomatic <italic toggle="yes">APOE4</italic> carriers, we found no evidence of divergence between <italic toggle="yes">MAPT/GRN</italic> carrier-control differences and <italic toggle="yes">APOE4</italic> carrier-control differences, even when restricting our DTI analysis to regions which are known to differ between FTD and AD patients. This may suggest that the neuroimaging biomarkers measured in this study are not sufficiently specific to differentiate between FTD-related pathology and pathology possibly related to AD at this early stage.</p><p id="Par49">Our lack of differences between groups in grey matter volume were unsurprising. In asymptomatic risk mutation carriers, one would not expect dementia related atrophy unless the carrier would be close to symptom onset. Indeed, grey matter volume differences have not been reported in asymptomatic <italic toggle="yes">MAPT/GRN</italic> mutation carriers [<xref ref-type="bibr" rid="CR31">31</xref>, <xref ref-type="bibr" rid="CR32">32</xref>], though reports in asymptomatic <italic toggle="yes">APOE4</italic> carriers have been conflicting. While some groups report no grey matter volume differences in asymptomatic <italic toggle="yes">APOE4</italic> carriers [<xref ref-type="bibr" rid="CR35">35</xref>, <xref ref-type="bibr" rid="CR39">39</xref>, <xref ref-type="bibr" rid="CR40">40</xref>, <xref ref-type="bibr" rid="CR43">43</xref>], others found reduced grey matter volume in the hippocampus [<xref ref-type="bibr" rid="CR36">36</xref>, <xref ref-type="bibr" rid="CR75">75</xref>], lingual gyrus [<xref ref-type="bibr" rid="CR36">36</xref>], precuneus [<xref ref-type="bibr" rid="CR36">36</xref>, <xref ref-type="bibr" rid="CR76">76</xref>], insula [<xref ref-type="bibr" rid="CR76">76</xref>], caudate nucleus, precentral gyrus, and cerebellar crus [<xref ref-type="bibr" rid="CR75">75</xref>]. These conflicting findings may in part result from methodological differences, sample sizes, and the different age ranges between studies. Since disease modifying treatments aim to prevent atrophy, one would ideally aim to diagnose dementia patients before atrophy occurs to maximise potential treatment effect. Accordingly, biomarker research should focus on detecting substrates of neurodegeneration that precede atrophy and that may be reversible by future disease modifying treatments.</p><p id="Par50">White matter diffusion analyses yielded areas of reduced FA in <italic toggle="yes">APOE4</italic> carriers compared to controls in the splenium of the corpus callosum, and in the right inferior fronto-occipital fasciculus. These results concur with previous reports in <italic toggle="yes">APOE4</italic> carriers. FA reductions were most often reported in the corpus callosum, cingulum, and inferior fronto-occipital fasciculi [<xref ref-type="bibr" rid="CR39">39</xref>, <xref ref-type="bibr" rid="CR44">44</xref>–<xref ref-type="bibr" rid="CR51">51</xref>], while FA differences in the corticospinal tract [<xref ref-type="bibr" rid="CR39">39</xref>, <xref ref-type="bibr" rid="CR49">49</xref>–<xref ref-type="bibr" rid="CR51">51</xref>] and superior longitudinal fasciculi [<xref ref-type="bibr" rid="CR39">39</xref>, <xref ref-type="bibr" rid="CR50">50</xref>, <xref ref-type="bibr" rid="CR51">51</xref>] were less frequently reported. We found no diffusion differences in <italic toggle="yes">MAPT/GRN</italic> mutation carriers compared to controls, in contrast to earlier work [<xref ref-type="bibr" rid="CR32">32</xref>, <xref ref-type="bibr" rid="CR33">33</xref>]. However, this might be explained by differences in methodology. One study found significant FA reductions only within certain pre-specified tracts, and, similar to our current study, found no whole-brain differences [<xref ref-type="bibr" rid="CR32">32</xref>]. The other study found differences at <italic toggle="yes">p</italic>&lt;0.005 uncorrected for multiple comparisons across space. Our analyses were performed with a more restrictive significance level, as we corrected for multiple comparisons across space using threshold-free cluster enhancement, and used the statistical threshold appropriate for a two-sided test, which is not a standard procedure in neuroimaging [<xref ref-type="bibr" rid="CR77">77</xref>]. Interestingly, DTI alterations are larger in FTD patients than in AD patients [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR13">13</xref>–<xref ref-type="bibr" rid="CR16">16</xref>], while preclinical alterations in <italic toggle="yes">APOE4</italic> carriers [<xref ref-type="bibr" rid="CR39">39</xref>, <xref ref-type="bibr" rid="CR44">44</xref>–<xref ref-type="bibr" rid="CR51">51</xref>] are more widespread than in <italic toggle="yes">MAPT/GRN</italic> mutation carriers [<xref ref-type="bibr" rid="CR32">32</xref>, <xref ref-type="bibr" rid="CR33">33</xref>]. Recently, it has been postulated that white matter DTI differences in genetic FTD develop rather explosively in the years just prior to symptom onset [<xref ref-type="bibr" rid="CR78">78</xref>, <xref ref-type="bibr" rid="CR79">79</xref>]. This might explain why in our sample, we found DTI differences in <italic toggle="yes">APOE4</italic> carriers, but no DTI differences in <italic toggle="yes">MAPT/GRN</italic> mutation carriers. Although there were FA reductions in <italic toggle="yes">APOE4</italic> carriers compared to controls, the difference was not strong enough to result in a difference between the <italic toggle="yes">MAPT/GRN</italic> carrier-control contrast and the <italic toggle="yes">APOE4</italic> carrier-control contrast. We also performed region-of-interest analyses in the uncinate fasciculi, forceps minor, or bilateral anterior thalamic radiations, which were found to have FA reductions and RD increases in FTD patients compared to AD patients [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR13">13</xref>–<xref ref-type="bibr" rid="CR16">16</xref>]. However, even in these regions of interest, we could not find DTI differences between the <italic toggle="yes">MAPT/GRN</italic> carrier-control contrast and the <italic toggle="yes">APOE4</italic> carrier-control contrast. As such, we could not conclude that <italic toggle="yes">MAPT/GRN</italic> mutation carriership had a different effect on white matter diffusion metrics than <italic toggle="yes">APOE4</italic> carriership.</p><p id="Par51">It has been previously argued that the default mode network and the salience network are inversely correlated and both play a role in AD and FTD. Specifically, functional connectivity in the default mode network was reported to be reduced in AD patients and increased in FTD patients, whereas functional connectivity in the salience network was reported to be inversely affected: reduced in FTD patients and increased in AD patients [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR17">17</xref>]. In asymptomatic <italic toggle="yes">APOE4</italic> carriers, this inverse correlation was also shown. Functional connectivity with the default mode network was decreased and functional connectivity with the salience network was enhanced in <italic toggle="yes">APOE4</italic> carriers compared to controls [<xref ref-type="bibr" rid="CR41">41</xref>]. In asymptomatic <italic toggle="yes">MAPT</italic> and <italic toggle="yes">GRN</italic> mutation carriers, functional connectivity was reduced in the salience network, but no differences in the default mode network were found [<xref ref-type="bibr" rid="CR32">32</xref>]. Based on these results, we hypothesised that functional connectivity in the default mode network and salience network would be ideal candidates to screen for early changes in asymptomatic risk carriers. However, we found no evidence of functional connectivity differences, either between the respective carrier and control groups or divergent differences between the carrier-control contrasts. This might in part be a power issue but could also be explained by population and methodological differences. For example, our sample was on average younger and had a broader age range than the <italic toggle="yes">APOE4</italic> sample investigated by Machulda et al. (2011) [<xref ref-type="bibr" rid="CR41">41</xref>]. Furthermore, we performed data-driven dual regression analyses, whereas both Machulda et al. (2011) [<xref ref-type="bibr" rid="CR41">41</xref>] and Dopper et al. (2014) [<xref ref-type="bibr" rid="CR32">32</xref>] performed seed-based analyses. While small seed areas are arbitrarily placed and may be subject to registration mismatch, dual regression networks are less sensitive to these issues due to their data-driven origin. Indeed, dual regression is amongst the best functional MRI analysis techniques in terms of test-retest reliability [<xref ref-type="bibr" rid="CR80">80</xref>, <xref ref-type="bibr" rid="CR81">81</xref>]. Therefore, the most likely explanation of our functional connectivity results is that our groups were on average too far from symptom onset for functional connectivity alterations in the default mode network and salience network to robustly appear.</p><p id="Par52">Strengths of this study include its unique design to pick up differences between FTD- and AD-related pathology in asymptomatic populations, and the inclusion of control groups from both sites to deal with potential scan site bias. We performed specific region-of-interest analyses to increase power to find differences in DTI metrics. Furthermore, we used FIX [<xref ref-type="bibr" rid="CR62">62</xref>, <xref ref-type="bibr" rid="CR63">63</xref>] to clean up structured noise (e.g., motion, artefacts) from rs-fMRI data to reduce scanner-based functional connectivity differences [<xref ref-type="bibr" rid="CR64">64</xref>] and increase the signal-to-noise ratio. To account for possible heterogeneity resulting from pooling <italic toggle="yes">MAPT</italic> and <italic toggle="yes">GRN</italic> mutation carriers, and <italic toggle="yes">APOE4</italic> hetero- and homozygotes, we performed additional analyses including covariates for the different mutation types. The results of these analyses were very similar to our main results, suggesting that the effect of genetic heterogeneity in our main analyses was altogether limited. Limitations must also be considered. Firstly, differences in penetrance and age of onset exist between <italic toggle="yes">MAPT/GRN</italic> and <italic toggle="yes">APOE4</italic>. <italic toggle="yes">MAPT</italic> and <italic toggle="yes">GRN</italic> mutations have an autosomal dominant inheritance pattern, and are highly penetrant [<xref ref-type="bibr" rid="CR82">82</xref>, <xref ref-type="bibr" rid="CR83">83</xref>]. On the other hand, <italic toggle="yes">APOE4</italic> has a dose-dependent effect on lifetime AD risk. Heterozygous <italic toggle="yes">APOE4</italic> carriers have an estimated lifetime risk for AD of approximately 25%, while <italic toggle="yes">APOE4</italic> homozygosity is associated with an estimated lifetime risk of around 55% [<xref ref-type="bibr" rid="CR84">84</xref>]. Therefore, it is unlikely that all <italic toggle="yes">APOE4</italic> carriers from our sample will develop AD, which reduced our power to detect AD-related differences. For the same reason, it cannot be entirely ruled out that some of the differences associated with the <italic toggle="yes">APOE4</italic> carriers do not reflect presymptomatic AD-related pathology. Information on <italic toggle="yes">MAPT/GRN</italic> mutation carriership was not available for <italic toggle="yes">APOE4</italic> carriers and controls, and information on <italic toggle="yes">APOE4</italic> carriership was not available for <italic toggle="yes">MAPT/GRN</italic> mutation carriers and controls. Due to the infrequency of <italic toggle="yes">MAPT</italic> and <italic toggle="yes">GRN</italic> mutations, it is unlikely that <italic toggle="yes">APOE4</italic> carriers or controls had an <italic toggle="yes">MAPT</italic> or <italic toggle="yes">GRN</italic> mutation. However, the frequency of the <italic toggle="yes">APOE4</italic> allele in Caucasian populations is around 14% [<xref ref-type="bibr" rid="CR85">85</xref>], and it is likely that some of the <italic toggle="yes">MAPT</italic> and <italic toggle="yes">GRN</italic> mutation carriers and controls had an <italic toggle="yes">APOE4</italic> allele. As <italic toggle="yes">MAPT/GRN</italic> mutation carriers and controls were from the same families, the frequency of the <italic toggle="yes">APOE4</italic> alleles within these groups was most likely similar. Therefore, the effect of <italic toggle="yes">APOE4</italic> on our <italic toggle="yes">MAPT/GRN</italic> analyses is presumably small. The broad age range in our groups presents another limitation. FTD- or AD-related pathology may be absent or present in a lesser degree in young mutation carriers than in older carriers, who are closer to symptom-onset. However, even though a broad age range was present in our sample, physiological brain aging effects are unlikely to have influenced our results. The four groups were matched for age, and age was added as confound covariate to the model. Therefore, physiological brain aging effects should be equally distributed across groups and were accounted for in the model. In order to increase power, future neuroimaging research comparing FTD- and AD-related pathology in asymptomatic risk groups should contain clinical follow-up and conversion information, which will enable the inclusion of a time to onset variable to the model.</p><p id="Par53">Dementias are relentlessly progressive diseases for which no adequate treatments currently exist, and differentiation between various forms of dementia is clinically challenging. Recently, MRI has shown different patterns of grey matter atrophy, DTI alterations and functional connectivity differences in AD and FTD patients [<xref ref-type="bibr" rid="CR11">11</xref>–<xref ref-type="bibr" rid="CR17">17</xref>]. However, early differential identification of at-risk groups is key to study pathophysiological processes, develop disease-modulating drugs and, eventually, identify patient groups that may benefit from these treatments. In the current study, we could not find differences suggestive of divergent pathways of underlying FTD and AD pathology in asymptomatic risk mutation carriers.</p></sec><sec sec-type="supplementary-material"><title>Supplementary information</title><sec id="Sec18"><p>
<supplementary-material content-type="local-data" id="MOESM1" position="float" orientation="portrait"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="12883_2019_1567_MOESM1_ESM.tif" position="float" orientation="portrait"><caption><p><bold>Additional file 1: Figure S1.</bold> Dual regression. Subject-specific spatial maps for statistical testing are acquired from group-level ICA spatial maps in two steps. First, group-level ICA spatial maps are used as spatial regressor on each subject’s rs-fMRI data to obtain time series associated with those ICA components (Step 1). Next, these time series are used as temporal regressor to obtain subject-specific spatial maps for each component (Step 2). These maps are then used for voxel-wise statistical testing. GICA, group-level independent component analysis; rs-fMRI, resting-state functional magnetic resonance imaging.</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM2" position="float" orientation="portrait"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="12883_2019_1567_MOESM2_ESM.tif" position="float" orientation="portrait"><caption><p><bold>Additional file 2: Figure S2.</bold> White matter FA analysis with mutation covariates. In this analysis, covariates were added for the difference between <italic toggle="yes">MAPT</italic> and <italic toggle="yes">GRN</italic> mutations, and between <italic toggle="yes">APOE4</italic> hetero- and homozygosity to account for genetic heterogeneity. Differences in FA (or lack thereof) are shown for each contrast (e.g., <italic toggle="yes">MAPT/GRN</italic> mutation carriers greater or smaller than controls; <italic toggle="yes">APOE4</italic> carriers greater or smaller than controls; <italic toggle="yes">MAPT/GRN</italic> carrier-control differences greater or smaller than <italic toggle="yes">APOE4</italic> carrier-control differences). Mean skeleton maps are shown in green; skeletonised significant results were thickened for better visualisation. One cluster of FA reductions was found in <italic toggle="yes">APOE4</italic> carriers compared to controls (middle left panel). Colour bar represents significance. <italic toggle="yes">APOE4, apolipoprotein E ε4</italic>; FA, fractional anisotropy; <italic toggle="yes">MAPT/GRN</italic>, <italic toggle="yes">microtubule-associated protein tau / progranulin</italic>.</p></caption></media></supplementary-material>
</p></sec></sec></body><back><glossary><title>Abbreviations</title><def-list><def-item><term>(rs-f)MRI</term><def><p id="Par5">(resting-state-functional) Magnetic resonance imaging</p></def></def-item><def-item><term>AD</term><def><p id="Par6">Alzheimer’s disease</p></def></def-item><def-item><term><italic toggle="yes">APOE4</italic></term><def><p id="Par7">
<italic toggle="yes">Apolipoprotein E ε4</italic>
</p></def></def-item><def-item><term>AxD</term><def><p id="Par8">Axial diffusivity</p></def></def-item><def-item><term>DTI</term><def><p id="Par9">Diffusion tensor imaging</p></def></def-item><def-item><term>FA</term><def><p id="Par10">Fractional anisotropy</p></def></def-item><def-item><term>FIX</term><def><p id="Par11">FMRIB’s ICA-based X-noiseifier</p></def></def-item><def-item><term>FMRIB</term><def><p id="Par12">Functional Magnetic Resonance Imaging of the Brain Centre</p></def></def-item><def-item><term>FSL</term><def><p id="Par13">FMRIB Software Library</p></def></def-item><def-item><term>FTD</term><def><p id="Par14">Frontotemporal dementia</p></def></def-item><def-item><term><italic toggle="yes">GRN</italic></term><def><p id="Par15">
<italic toggle="yes">Progranulin</italic>
</p></def></def-item><def-item><term>ICA</term><def><p id="Par16">Independent component analysis</p></def></def-item><def-item><term>LUMC</term><def><p id="Par17">Leiden University Medical Centre</p></def></def-item><def-item><term>MAPT</term><def><p id="Par18">Microtubule-associated protein Tau</p></def></def-item><def-item><term>MD</term><def><p id="Par19">Mean diffusivity</p></def></def-item><def-item><term>RD</term><def><p id="Par20">Radial diffusivity</p></def></def-item></def-list></glossary><fn-group><fn><p><bold>Publisher’s Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><sec><title>Supplementary information</title><p><bold>Supplementary information</bold> accompanies this paper at 10.1186/s12883-019-1567-0.</p></sec><ack><title>Acknowledgements</title><p>Our appreciation goes out to all study participants.</p></ack><notes notes-type="author-contribution"><title>Authors’ contributions</title><p>RF, JS, MAB, CM and SR were involved in the design of the study. ED, NF, VH and AT acquired the MRI data. RF, MJB, CM, NF and VH contributed to the analyses. RF, MJB, NF, VH, JG, CM and SR contributed to the interpretation of the results. RF was responsible for drafting the manuscript. Finally, all authors provided feedback and contributed to the final manuscript.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>The authors of this work were supported by the Leiden University Medical Centre MD/PhD Scholarship (to RF); HDH Wills 1965 charitable trusts (to NF, English Charity Register 1117747); an Alzheimer’s Research UK studentship (to VH, English Charity Register 1077089); a Rhodes scholarship (to AT); ZonMw programme Memorabel project 733050103, JPND PreFrontAls consortium project 733051042 (to JS), the National Institute for Health Research (NIHR), UK as part of the Oxford Biomedical Research Centre (BRC; to CM) and a VICI grant 016-130-667 from The Netherlands Organisation for Scientific Research (NWO; to SR). The views expressed are those of the authors and not necessarily those of the NWO, the NHS or the NIHR. The funding sources were not involved in the design of the study; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the article for publication.</p></notes><notes notes-type="data-availability"><title>Availability of data and materials</title><p>The datasets and scripts used during the current study are available from the corresponding author on reasonable request. All non-thresholded statistical images for grey matter volume, white matter diffusion, and functional connectivity results can be found on NeuroVault [<xref ref-type="bibr" rid="CR74">74</xref>]: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://neurovault.org/collections/NXLXKVCZ/">https://neurovault.org/collections/NXLXKVCZ/</ext-link>.</p></notes><notes><title>Ethics approval and consent to participate</title><p id="Par54">The study was conducted in accordance with regional regulations and the Declaration of Helsinki. Written informed consent was received from all participants, and ethical approval for data acquisition was provided by the Medical Ethical Committees in Rotterdam and Leiden for <italic toggle="yes">MAPT/GRN</italic> data, and the National Research Ethics Service Committee South Central – Oxford C for <italic toggle="yes">APOE4</italic> data.</p></notes><notes><title>Consent for publication</title><p id="Par55">Not applicable.</p></notes><notes notes-type="COI-statement"><title>Competing interests</title><p id="Par56">The authors declare that they have no competing interests.</p></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lobo</surname><given-names>A</given-names></name><name name-style="western"><surname>Launer</surname><given-names>LJ</given-names></name><name name-style="western"><surname>Fratiglioni</surname><given-names>L</given-names></name><etal/></person-group><article-title>Prevalence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts</article-title><source>Neurology</source><year>2000</year><volume>54</volume><issue>11 Suppl 5</issue><fpage>S4</fpage><lpage>S9</lpage><pub-id pub-id-type="pmid">10854354</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Plassman</surname><given-names>BL</given-names></name><name name-style="western"><surname>Langa</surname><given-names>KM</given-names></name><name name-style="western"><surname>Fisher</surname><given-names>GG</given-names></name><etal/></person-group><article-title>Prevalence of dementia in the United States: The aging, demographics, and memory study</article-title><source>Neuroepidemiology</source><year>2007</year><volume>29</volume><issue>1–2</issue><fpage>125</fpage><lpage>132</lpage><pub-id pub-id-type="doi">10.1159/000109998</pub-id><pub-id pub-id-type="pmid">17975326</pub-id><pub-id pub-id-type="pmcid">PMC2705925</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Seelaar</surname><given-names>H</given-names></name><name name-style="western"><surname>Kamphorst</surname><given-names>W</given-names></name><name name-style="western"><surname>Rosso</surname><given-names>SM</given-names></name><etal/></person-group><article-title>Distinct genetic forms of frontotemporal dementia</article-title><source>Neurology.</source><year>2008</year><volume>71</volume><issue>16</issue><fpage>1220</fpage><lpage>1226</lpage><pub-id pub-id-type="doi">10.1212/01.wnl.0000319702.37497.72</pub-id><pub-id pub-id-type="pmid">18703462</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vieira</surname><given-names>RT</given-names></name><name name-style="western"><surname>Caixeta</surname><given-names>L</given-names></name><name name-style="western"><surname>Machado</surname><given-names>S</given-names></name><etal/></person-group><article-title>Epidemiology of early-onset dementia: a review of the literature</article-title><source>Clin Pract Epidemiol Ment Health</source><year>2013</year><volume>9</volume><fpage>88</fpage><lpage>95</lpage><pub-id pub-id-type="doi">10.2174/1745017901309010088</pub-id><pub-id pub-id-type="pmid">23878613</pub-id><pub-id pub-id-type="pmcid">PMC3715758</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rascovsky</surname><given-names>K</given-names></name><name name-style="western"><surname>Hodges</surname><given-names>JR</given-names></name><name name-style="western"><surname>Knopman</surname><given-names>D</given-names></name><etal/></person-group><article-title>Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia</article-title><source>Brain</source><year>2011</year><volume>134</volume><issue>9</issue><fpage>2456</fpage><lpage>2477</lpage><pub-id pub-id-type="doi">10.1093/brain/awr179</pub-id><pub-id pub-id-type="pmid">21810890</pub-id><pub-id pub-id-type="pmcid">PMC3170532</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gorno-Tempini</surname><given-names>ML</given-names></name><name name-style="western"><surname>Hillis</surname><given-names>AE</given-names></name><name name-style="western"><surname>Weintraub</surname><given-names>S</given-names></name><etal/></person-group><article-title>Classification of primary progressive aphasia and its variants</article-title><source>Neurology</source><year>2011</year><volume>76</volume><issue>11</issue><fpage>1006</fpage><lpage>1014</lpage><pub-id pub-id-type="doi">10.1212/WNL.0b013e31821103e6</pub-id><pub-id pub-id-type="pmid">21325651</pub-id><pub-id pub-id-type="pmcid">PMC3059138</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McKhann</surname><given-names>GM</given-names></name><name name-style="western"><surname>Knopman</surname><given-names>DS</given-names></name><name name-style="western"><surname>Chertkow</surname><given-names>H</given-names></name><etal/></person-group><article-title>The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease</article-title><source>Alzheimers Dement</source><year>2011</year><volume>7</volume><issue>3</issue><fpage>263</fpage><lpage>269</lpage><pub-id pub-id-type="doi">10.1016/j.jalz.2011.03.005</pub-id><pub-id pub-id-type="pmid">21514250</pub-id><pub-id pub-id-type="pmcid">PMC3312024</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Seelaar</surname><given-names>H</given-names></name><name name-style="western"><surname>Rohrer</surname><given-names>JD</given-names></name><name name-style="western"><surname>Pijnenburg</surname><given-names>YAL</given-names></name><name name-style="western"><surname>Fox</surname><given-names>NC</given-names></name><name name-style="western"><surname>van Swieten</surname><given-names>JC</given-names></name></person-group><article-title>Clinical, genetic and pathological heterogeneity of frontotemporal dementia: a review</article-title><source>J Neurol Neurosurg Psychiatry</source><year>2011</year><volume>82</volume><issue>5</issue><fpage>476</fpage><lpage>486</lpage><pub-id pub-id-type="doi">10.1136/jnnp.2010.212225</pub-id><pub-id pub-id-type="pmid">20971753</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Galimberti</surname><given-names>D</given-names></name><name name-style="western"><surname>Scarpini</surname><given-names>E</given-names></name></person-group><article-title>Clinical phenotypes and genetic biomarkers of FTLD</article-title><source>J Neural Transm</source><year>2012</year><volume>119</volume><issue>7</issue><fpage>851</fpage><lpage>860</lpage><pub-id pub-id-type="doi">10.1007/s00702-012-0804-0</pub-id><pub-id pub-id-type="pmid">22527778</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Seeley</surname><given-names>WW</given-names></name><name name-style="western"><surname>Allman</surname><given-names>JM</given-names></name><name name-style="western"><surname>Carlin</surname><given-names>DA</given-names></name><etal/></person-group><article-title>Divergent social functioning in behavioral variant frontotemporal dementia and Alzheimer disease: reciprocal networks and neuronal evolution</article-title><source>Alzheimer Dis Assoc Disord</source><year>2007</year><volume>21</volume><issue>4</issue><fpage>S50</fpage><lpage>S57</lpage><pub-id pub-id-type="doi">10.1097/WAD.0b013e31815c0f14</pub-id><pub-id pub-id-type="pmid">18090425</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Schuff</surname><given-names>N</given-names></name><name name-style="western"><surname>Du</surname><given-names>A-T</given-names></name><etal/></person-group><article-title>White matter damage in frontotemporal dementia and Alzheimer’s disease measured by diffusion MRI</article-title><source>Brain</source><year>2009</year><volume>132</volume><issue>9</issue><fpage>2579</fpage><lpage>2592</lpage><pub-id pub-id-type="doi">10.1093/brain/awp071</pub-id><pub-id pub-id-type="pmid">19439421</pub-id><pub-id pub-id-type="pmcid">PMC2732263</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhou</surname><given-names>J</given-names></name><name name-style="western"><surname>Greicius</surname><given-names>MD</given-names></name><name name-style="western"><surname>Gennatas</surname><given-names>ED</given-names></name><etal/></person-group><article-title>Divergent network connectivity changes in behavioural variant frontotemporal dementia and Alzheimer’s disease</article-title><source>Brain</source><year>2010</year><volume>133</volume><issue>5</issue><fpage>1352</fpage><lpage>1367</lpage><pub-id pub-id-type="doi">10.1093/brain/awq075</pub-id><pub-id pub-id-type="pmid">20410145</pub-id><pub-id pub-id-type="pmcid">PMC2912696</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><mixed-citation publication-type="other">Zhang Y, Schuff N, Ching C, et al. Joint assessment of structural, perfusion, and diffusion MRI in Alzheimer’s disease and frontotemporal dementia. Int J Alzheimers Dis. 2011;546871.<pub-id pub-id-type="doi" assigning-authority="pmc">10.4061/2011/546871</pub-id><pub-id pub-id-type="pmcid">PMC3132541</pub-id><pub-id pub-id-type="pmid">21760989</pub-id></mixed-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mahoney</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Ridgway</surname><given-names>GR</given-names></name><name name-style="western"><surname>Malone</surname><given-names>IB</given-names></name><etal/></person-group><article-title>Profiles of white matter tract pathology in frontotemporal dementia</article-title><source>Hum Brain Mapp</source><year>2014</year><volume>35</volume><issue>8</issue><fpage>4163</fpage><lpage>4179</lpage><pub-id pub-id-type="doi">10.1002/hbm.22468</pub-id><pub-id pub-id-type="pmid">24510641</pub-id><pub-id pub-id-type="pmcid">PMC4312919</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Möller</surname><given-names>C</given-names></name><name name-style="western"><surname>Hafkemeijer</surname><given-names>A</given-names></name><name name-style="western"><surname>Pijnenburg</surname><given-names>YAL</given-names></name><etal/></person-group><article-title>Joint assessment of white matter integrity, cortical and subcortical atrophy to distinguish AD from behavioral variant FTD: A two-center study</article-title><source>NeuroImage Clin</source><year>2015</year><volume>9</volume><fpage>418</fpage><lpage>429</lpage><pub-id pub-id-type="doi">10.1016/j.nicl.2015.08.022</pub-id><pub-id pub-id-type="pmid">26594624</pub-id><pub-id pub-id-type="pmcid">PMC4600847</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Daianu</surname><given-names>M</given-names></name><name name-style="western"><surname>Mendez</surname><given-names>MF</given-names></name><name name-style="western"><surname>Baboyan</surname><given-names>VG</given-names></name><etal/></person-group><article-title>An advanced white matter tract analysis in frontotemporal dementia and early-onset Alzheimer’s disease</article-title><source>Brain Imaging Behav</source><year>2016</year><volume>10</volume><issue>4</issue><fpage>1038</fpage><lpage>1053</lpage><pub-id pub-id-type="doi">10.1007/s11682-015-9458-5</pub-id><pub-id pub-id-type="pmid">26515192</pub-id><pub-id pub-id-type="pmcid">PMC5167220</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tuovinen</surname><given-names>T</given-names></name><name name-style="western"><surname>Rytty</surname><given-names>R</given-names></name><name name-style="western"><surname>Moilanen</surname><given-names>V</given-names></name><etal/></person-group><article-title>The Effect of Gray Matter ICA and Coefficient of Variation Mapping of BOLD Data on the Detection of Functional Connectivity Changes in Alzheimer’s Disease and bvFTD</article-title><source>Front Hum Neurosci</source><year>2017</year><volume>10</volume><fpage>680</fpage><pub-id pub-id-type="doi">10.3389/fnhum.2016.00680</pub-id><pub-id pub-id-type="pmid">28119587</pub-id><pub-id pub-id-type="pmcid">PMC5220074</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Graham</surname><given-names>A</given-names></name><name name-style="western"><surname>Davies</surname><given-names>R</given-names></name><name name-style="western"><surname>Xuereb</surname><given-names>J</given-names></name><etal/></person-group><article-title>Pathologically proven frontotemporal dementia presenting with severe amnesia</article-title><source>Brain</source><year>2005</year><volume>128</volume><issue>3</issue><fpage>597</fpage><lpage>605</lpage><pub-id pub-id-type="doi">10.1093/brain/awh348</pub-id><pub-id pub-id-type="pmid">15634737</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Le Ber</surname><given-names>I</given-names></name><name name-style="western"><surname>Camuzat</surname><given-names>A</given-names></name><name name-style="western"><surname>Hannequin</surname><given-names>D</given-names></name><etal/></person-group><article-title>Phenotype variability in progranulin mutation carriers: a clinical, neuropsychological, imaging and genetic study</article-title><source>Brain</source><year>2008</year><volume>131</volume><issue>Pt 3</issue><fpage>732</fpage><lpage>746</lpage><pub-id pub-id-type="doi">10.1093/brain/awn012</pub-id><pub-id pub-id-type="pmid">18245784</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Johnson</surname><given-names>Julene K.</given-names></name><name name-style="western"><surname>Head</surname><given-names>Elizabeth</given-names></name><name name-style="western"><surname>Kim</surname><given-names>Ronald</given-names></name><name name-style="western"><surname>Starr</surname><given-names>Arnold</given-names></name><name name-style="western"><surname>Cotman</surname><given-names>Carl W.</given-names></name></person-group><article-title>Clinical and Pathological Evidence for a Frontal Variant of Alzheimer Disease</article-title><source>Archives of Neurology</source><year>1999</year><volume>56</volume><issue>10</issue><fpage>1233</fpage><pub-id pub-id-type="doi">10.1001/archneur.56.10.1233</pub-id><pub-id pub-id-type="pmid">10520939</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mendez</surname><given-names>Mario F.</given-names></name><name name-style="western"><surname>Shapira</surname><given-names>Jill S.</given-names></name><name name-style="western"><surname>McMurtray</surname><given-names>Aaron</given-names></name><name name-style="western"><surname>Licht</surname><given-names>Eliot</given-names></name><name name-style="western"><surname>Miller</surname><given-names>Bruce L.</given-names></name></person-group><article-title>Accuracy of the Clinical Evaluation for Frontotemporal Dementia</article-title><source>Archives of Neurology</source><year>2007</year><volume>64</volume><issue>6</issue><fpage>830</fpage><pub-id pub-id-type="doi">10.1001/archneur.64.6.830</pub-id><pub-id pub-id-type="pmid">17562930</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Forman</surname><given-names>MS</given-names></name><name name-style="western"><surname>Farmer</surname><given-names>J</given-names></name><name name-style="western"><surname>Johnson</surname><given-names>JK</given-names></name><etal/></person-group><article-title>Frontotemporal dementia: Clinicopathological correlations</article-title><source>Ann Neurol</source><year>2006</year><volume>59</volume><issue>6</issue><fpage>952</fpage><lpage>962</lpage><pub-id pub-id-type="doi">10.1002/ana.20873</pub-id><pub-id pub-id-type="pmid">16718704</pub-id><pub-id pub-id-type="pmcid">PMC2629792</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Knibb</surname><given-names>JA</given-names></name><name name-style="western"><surname>Xuereb</surname><given-names>JH</given-names></name><name name-style="western"><surname>Patterson</surname><given-names>K</given-names></name><name name-style="western"><surname>Hodges</surname><given-names>JR</given-names></name></person-group><article-title>Clinical and pathological characterization of progressive aphasia</article-title><source>Ann Neurol</source><year>2006</year><volume>59</volume><issue>1</issue><fpage>156</fpage><lpage>165</lpage><pub-id pub-id-type="doi">10.1002/ana.20700</pub-id><pub-id pub-id-type="pmid">16374817</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alladi</surname><given-names>S</given-names></name><name name-style="western"><surname>Xuereb</surname><given-names>J</given-names></name><name name-style="western"><surname>Bak</surname><given-names>T</given-names></name><etal/></person-group><article-title>Focal cortical presentations of Alzheimer’s disease</article-title><source>Brain</source><year>2007</year><volume>130</volume><issue>10</issue><fpage>2636</fpage><lpage>2645</lpage><pub-id pub-id-type="doi">10.1093/brain/awm213</pub-id><pub-id pub-id-type="pmid">17898010</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mohs</surname><given-names>RC</given-names></name><name name-style="western"><surname>Doody</surname><given-names>RS</given-names></name><name name-style="western"><surname>Morris</surname><given-names>JC</given-names></name><etal/></person-group><article-title>A 1-year, placebo-controlled preservation of function survival study of donepezil in AD patients</article-title><source>Neurology</source><year>2001</year><volume>57</volume><issue>3</issue><fpage>481</fpage><lpage>488</lpage><pub-id pub-id-type="doi">10.1212/WNL.57.3.481</pub-id><pub-id pub-id-type="pmid">11502917</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Mendez</surname><given-names>MF</given-names></name></person-group><person-group person-group-type="editor"><name name-style="western"><surname>Giannakopoulos</surname><given-names>P</given-names></name><name name-style="western"><surname>Hof</surname><given-names>PR</given-names></name></person-group><article-title>Frontotemporal Dementia: Therapeutic Interventions</article-title><source>Dementia in Clinical Practice</source><year>2009</year><publisher-loc>Basel</publisher-loc><publisher-name>KARGER</publisher-name><fpage>168</fpage><lpage>178</lpage></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pressman</surname><given-names>PS</given-names></name><name name-style="western"><surname>Miller</surname><given-names>BL</given-names></name></person-group><article-title>Diagnosis and Management of Behavioral Variant Frontotemporal Dementia</article-title><source>Biol Psychiatry</source><year>2014</year><volume>75</volume><issue>7</issue><fpage>574</fpage><lpage>581</lpage><pub-id pub-id-type="doi">10.1016/j.biopsych.2013.11.006</pub-id><pub-id pub-id-type="pmid">24315411</pub-id><pub-id pub-id-type="pmcid">PMC4194080</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rabinovici</surname><given-names>GD</given-names></name><name name-style="western"><surname>Miller</surname><given-names>BL</given-names></name></person-group><article-title>Frontotemporal Lobar Degeneration</article-title><source>CNS Drugs</source><year>2010</year><volume>24</volume><issue>5</issue><fpage>375</fpage><lpage>398</lpage><pub-id pub-id-type="doi">10.2165/11533100-000000000-00000</pub-id><pub-id pub-id-type="pmid">20369906</pub-id><pub-id pub-id-type="pmcid">PMC2916644</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Whitwell</surname><given-names>JL</given-names></name><name name-style="western"><surname>Weigand</surname><given-names>SD</given-names></name><name name-style="western"><surname>Gunter</surname><given-names>JL</given-names></name><etal/></person-group><article-title>Trajectories of brain and hippocampal atrophy in FTD with mutations in MAPT or GRN</article-title><source>Neurology</source><year>2011</year><volume>77</volume><issue>4</issue><fpage>393</fpage><lpage>398</lpage><pub-id pub-id-type="doi">10.1212/WNL.0b013e318227047f</pub-id><pub-id pub-id-type="pmid">21753165</pub-id><pub-id pub-id-type="pmcid">PMC3140800</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Whitwell</surname><given-names>JL</given-names></name><name name-style="western"><surname>Josephs</surname><given-names>KA</given-names></name><name name-style="western"><surname>Avula</surname><given-names>R</given-names></name><etal/></person-group><article-title>Altered functional connectivity in asymptomatic MAPT subjects: a comparison to bvFTD</article-title><source>Neurology</source><year>2011</year><volume>77</volume><issue>9</issue><fpage>866</fpage><lpage>874</lpage><pub-id pub-id-type="doi">10.1212/WNL.0b013e31822c61f2</pub-id><pub-id pub-id-type="pmid">21849646</pub-id><pub-id pub-id-type="pmcid">PMC3162637</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Borroni</surname><given-names>B</given-names></name><name name-style="western"><surname>Alberici</surname><given-names>A</given-names></name><name name-style="western"><surname>Cercignani</surname><given-names>M</given-names></name><etal/></person-group><article-title>Granulin mutation drives brain damage and reorganization from preclinical to symptomatic FTLD</article-title><source>Neurobiol Aging</source><year>2012</year><volume>33</volume><issue>10</issue><fpage>2506</fpage><lpage>2520</lpage><pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2011.10.031</pub-id><pub-id pub-id-type="pmid">22130207</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dopper</surname><given-names>EGP</given-names></name><name name-style="western"><surname>Rombouts</surname><given-names>SARB</given-names></name><name name-style="western"><surname>Jiskoot</surname><given-names>LC</given-names></name><etal/></person-group><article-title>Structural and functional brain connectivity in presymptomatic familial frontotemporal dementia</article-title><source>Neurology</source><year>2014</year><volume>83</volume><issue>2</issue><fpage>e19</fpage><lpage>e26</lpage><pub-id pub-id-type="doi">10.1212/WNL.0000000000000583</pub-id><pub-id pub-id-type="pmid">25002573</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pievani</surname><given-names>M</given-names></name><name name-style="western"><surname>Paternicò</surname><given-names>D</given-names></name><name name-style="western"><surname>Benussi</surname><given-names>L</given-names></name><etal/></person-group><article-title>Pattern of structural and functional brain abnormalities in asymptomatic granulin mutation carriers</article-title><source>Alzheimers Dement</source><year>2014</year><volume>10</volume><issue>Suppl 5</issue><fpage>S354</fpage><lpage>S363</lpage><pub-id pub-id-type="doi">10.1016/j.jalz.2013.09.009</pub-id><pub-id pub-id-type="pmid">24418059</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nierenberg</surname><given-names>J</given-names></name><name name-style="western"><surname>Pomara</surname><given-names>N</given-names></name><name name-style="western"><surname>Hoptman</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Sidtis</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Ardekani</surname><given-names>BA</given-names></name><name name-style="western"><surname>Lim</surname><given-names>KO</given-names></name></person-group><article-title>Abnormal white matter integrity in healthy apolipoprotein E epsilon4 carriers</article-title><source>Neuroreport</source><year>2005</year><volume>16</volume><issue>12</issue><fpage>1369</fpage><lpage>1372</lpage><pub-id pub-id-type="doi">10.1097/01.wnr.0000174058.49521.16</pub-id><pub-id pub-id-type="pmid">16056141</pub-id></element-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cherbuin</surname><given-names>N</given-names></name><name name-style="western"><surname>Anstey</surname><given-names>KJ</given-names></name><name name-style="western"><surname>Sachdev</surname><given-names>PS</given-names></name><etal/></person-group><article-title>Total and regional gray matter volume is not related to APOE*E4 status in a community sample of middle-aged individuals</article-title><source>J Gerontol Ser A</source><year>2008</year><volume>63</volume><issue>5</issue><fpage>501</fpage><lpage>504</lpage><pub-id pub-id-type="doi">10.1093/gerona/63.5.501</pub-id><pub-id pub-id-type="pmid">18511754</pub-id></element-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Honea</surname><given-names>RA</given-names></name><name name-style="western"><surname>Vidoni</surname><given-names>E</given-names></name><name name-style="western"><surname>Harsha</surname><given-names>A</given-names></name><name name-style="western"><surname>Burns</surname><given-names>JM</given-names></name></person-group><article-title>Impact of APOE on the Healthy Aging Brain: A Voxel-Based MRI and DTI Study</article-title><source>J Alzheimers Dis</source><year>2009</year><volume>18</volume><fpage>553</fpage><lpage>564</lpage><pub-id pub-id-type="doi">10.3233/JAD-2009-1163</pub-id><pub-id pub-id-type="pmid">19584447</pub-id><pub-id pub-id-type="pmcid">PMC2892293</pub-id></element-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Filippini</surname><given-names>N</given-names></name><name name-style="western"><surname>MacIntosh</surname><given-names>BJ</given-names></name><name name-style="western"><surname>Hough</surname><given-names>MG</given-names></name><etal/></person-group><article-title>Distinct patterns of brain activity in young carriers of the APOE-epsilon4 allele</article-title><source>Proc Natl Acad Sci U S A</source><year>2009</year><volume>106</volume><issue>17</issue><fpage>7209</fpage><lpage>7214</lpage><pub-id pub-id-type="doi">10.1073/pnas.0811879106</pub-id><pub-id pub-id-type="pmid">19357304</pub-id><pub-id pub-id-type="pmcid">PMC2678478</pub-id></element-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Agosta</surname><given-names>F</given-names></name><name name-style="western"><surname>Vossel</surname><given-names>KA</given-names></name><name name-style="western"><surname>Miller</surname><given-names>BL</given-names></name><etal/></person-group><article-title>Apolipoprotein E epsilon4 is associated with disease-specific effects on brain atrophy in Alzheimer’s disease and frontotemporal dementia</article-title><source>Proc Natl Acad Sci U S A</source><year>2009</year><volume>106</volume><issue>6</issue><fpage>2018</fpage><lpage>2022</lpage><pub-id pub-id-type="doi">10.1073/pnas.0812697106</pub-id><pub-id pub-id-type="pmid">19164761</pub-id><pub-id pub-id-type="pmcid">PMC2644156</pub-id></element-citation></ref><ref id="CR39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Heise</surname><given-names>V</given-names></name><name name-style="western"><surname>Filippini</surname><given-names>N</given-names></name><name name-style="western"><surname>Ebmeier</surname><given-names>KP</given-names></name><name name-style="western"><surname>Mackay</surname><given-names>CE</given-names></name></person-group><article-title>The APOE ɛ4 allele modulates brain white matter integrity in healthy adults</article-title><source>Mol Psychiatry</source><year>2011</year><volume>16</volume><issue>9</issue><fpage>908</fpage><lpage>916</lpage><pub-id pub-id-type="doi">10.1038/mp.2010.90</pub-id><pub-id pub-id-type="pmid">20820167</pub-id></element-citation></ref><ref id="CR40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Filippini</surname><given-names>N</given-names></name><name name-style="western"><surname>Ebmeier</surname><given-names>KP</given-names></name><name name-style="western"><surname>MacIntosh</surname><given-names>BJ</given-names></name><etal/></person-group><article-title>Differential effects of the APOE genotype on brain function across the lifespan</article-title><source>Neuroimage</source><year>2011</year><volume>54</volume><issue>1</issue><fpage>602</fpage><lpage>610</lpage><pub-id pub-id-type="doi">10.1016/j.neuroimage.2010.08.009</pub-id><pub-id pub-id-type="pmid">20705142</pub-id></element-citation></ref><ref id="CR41"><label>41.</label><mixed-citation publication-type="other">Machulda MM, Jones DT, Vemuri P, et al. Effect of APOE ε4 Status on Intrinsic Network Connectivity in Cognitively Normal Elderly Subjects. Arch Neurol. 2011;68(9):1131–6.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/archneurol.2011.108</pub-id><pub-id pub-id-type="pmcid">PMC3392960</pub-id><pub-id pub-id-type="pmid">21555604</pub-id></mixed-citation></ref><ref id="CR42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Trachtenberg</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Filippini</surname><given-names>N</given-names></name><name name-style="western"><surname>Ebmeier</surname><given-names>KP</given-names></name><name name-style="western"><surname>Smith</surname><given-names>SM</given-names></name><name name-style="western"><surname>Karpe</surname><given-names>F</given-names></name><name name-style="western"><surname>Mackay</surname><given-names>CE</given-names></name></person-group><article-title>The effects of APOE on the functional architecture of the resting brain</article-title><source>Neuroimage</source><year>2012</year><volume>59</volume><issue>1</issue><fpage>565</fpage><lpage>572</lpage><pub-id pub-id-type="doi">10.1016/j.neuroimage.2011.07.059</pub-id><pub-id pub-id-type="pmid">21851856</pub-id></element-citation></ref><ref id="CR43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Matura</surname><given-names>S</given-names></name><name name-style="western"><surname>Prvulovic</surname><given-names>D</given-names></name><name name-style="western"><surname>Jurcoane</surname><given-names>A</given-names></name><etal/></person-group><article-title>Differential effects of the ApoE4 genotype on brain structure and function</article-title><source>Neuroimage</source><year>2014</year><volume>89</volume><fpage>81</fpage><lpage>91</lpage><pub-id pub-id-type="doi">10.1016/j.neuroimage.2013.11.042</pub-id><pub-id pub-id-type="pmid">24296331</pub-id></element-citation></ref><ref id="CR44"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Persson</surname><given-names>J</given-names></name><name name-style="western"><surname>Lind</surname><given-names>J</given-names></name><name name-style="western"><surname>Larsson</surname><given-names>A</given-names></name><etal/></person-group><article-title>Altered brain white matter integrity in healthy carriers of the APOE epsilon4 allele: a risk for AD?</article-title><source>Neurology</source><year>2006</year><volume>66</volume><issue>7</issue><fpage>1029</fpage><lpage>1033</lpage><pub-id pub-id-type="doi">10.1212/01.wnl.0000204180.25361.48</pub-id><pub-id pub-id-type="pmid">16606914</pub-id></element-citation></ref><ref id="CR45"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Smith</surname><given-names>CD</given-names></name><name name-style="western"><surname>Chebrolu</surname><given-names>H</given-names></name><name name-style="western"><surname>Andersen</surname><given-names>AH</given-names></name><etal/></person-group><article-title>White matter diffusion alterations in normal women at risk of Alzheimer’s disease</article-title><source>Neurobiol Aging</source><year>2010</year><volume>31</volume><issue>7</issue><fpage>1122</fpage><lpage>1131</lpage><pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2008.08.006</pub-id><pub-id pub-id-type="pmid">18801597</pub-id><pub-id pub-id-type="pmcid">PMC2873054</pub-id></element-citation></ref><ref id="CR46"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gold</surname><given-names>BT</given-names></name><name name-style="western"><surname>Powell</surname><given-names>DK</given-names></name><name name-style="western"><surname>Andersen</surname><given-names>AH</given-names></name><name name-style="western"><surname>Smith</surname><given-names>CD</given-names></name></person-group><article-title>Alterations in multiple measures of white matter integrity in normal women at high risk for Alzheimer’s disease</article-title><source>Neuroimage</source><year>2010</year><volume>52</volume><issue>4</issue><fpage>1487</fpage><lpage>1494</lpage><pub-id pub-id-type="doi">10.1016/j.neuroimage.2010.05.036</pub-id><pub-id pub-id-type="pmid">20493952</pub-id><pub-id pub-id-type="pmcid">PMC2910213</pub-id></element-citation></ref><ref id="CR47"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Adluru</surname><given-names>N</given-names></name><name name-style="western"><surname>Destiche</surname><given-names>DJ</given-names></name><name name-style="western"><surname>Lu</surname><given-names>SY-F</given-names></name><etal/></person-group><article-title>White matter microstructure in late middle-age: Effects of apolipoprotein E4 and parental family history of Alzheimer’s disease</article-title><source>NeuroImage Clin</source><year>2014</year><volume>4</volume><fpage>730</fpage><lpage>742</lpage><pub-id pub-id-type="doi">10.1016/j.nicl.2014.04.008</pub-id><pub-id pub-id-type="pmid">24936424</pub-id><pub-id pub-id-type="pmcid">PMC4053649</pub-id></element-citation></ref><ref id="CR48"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lyall</surname><given-names>DM</given-names></name><name name-style="western"><surname>Harris</surname><given-names>SE</given-names></name><name name-style="western"><surname>Bastin</surname><given-names>ME</given-names></name><etal/></person-group><article-title>Alzheimer’s disease susceptibility genes APOE and TOMM40, and brain white matter integrity in the Lothian Birth Cohort 1936</article-title><source>Neurobiol Aging</source><year>2014</year><volume>35</volume><issue>6</issue><fpage>1513</fpage><pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2014.01.006</pub-id><pub-id pub-id-type="pmid">24508314</pub-id><pub-id pub-id-type="pmcid">PMC3969262</pub-id></element-citation></ref><ref id="CR49"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Laukka</surname><given-names>Erika J.</given-names></name><name name-style="western"><surname>Lövdén</surname><given-names>Martin</given-names></name><name name-style="western"><surname>Kalpouzos</surname><given-names>Grégoria</given-names></name><name name-style="western"><surname>Papenberg</surname><given-names>Goran</given-names></name><name name-style="western"><surname>Keller</surname><given-names>Lina</given-names></name><name name-style="western"><surname>Graff</surname><given-names>Caroline</given-names></name><name name-style="western"><surname>Li</surname><given-names>Tie-Qiang</given-names></name><name name-style="western"><surname>Fratiglioni</surname><given-names>Laura</given-names></name><name name-style="western"><surname>Bäckman</surname><given-names>Lars</given-names></name></person-group><article-title>Microstructural White Matter Properties Mediate the Association between APOE and Perceptual Speed in Very Old Persons without Dementia</article-title><source>PLOS ONE</source><year>2015</year><volume>10</volume><issue>8</issue><fpage>e0134766</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0134766</pub-id><pub-id pub-id-type="pmid">26252210</pub-id><pub-id pub-id-type="pmcid">PMC4529164</pub-id></element-citation></ref><ref id="CR50"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cavedo</surname><given-names>E</given-names></name><name name-style="western"><surname>Lista</surname><given-names>S</given-names></name><name name-style="western"><surname>Rojkova</surname><given-names>K</given-names></name><etal/></person-group><article-title>Disrupted white matter structural networks in healthy older adult APOE ε4 carriers – An international multicenter DTI study</article-title><source>Neuroscience</source><year>2017</year><volume>357</volume><fpage>119</fpage><lpage>133</lpage><pub-id pub-id-type="doi">10.1016/j.neuroscience.2017.05.048</pub-id><pub-id pub-id-type="pmid">28596117</pub-id></element-citation></ref><ref id="CR51"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Operto</surname><given-names>G</given-names></name><name name-style="western"><surname>Cacciaglia</surname><given-names>R</given-names></name><name name-style="western"><surname>Grau-Rivera</surname><given-names>O</given-names></name><etal/></person-group><article-title>White matter microstructure is altered in cognitively normal middle-aged APOE-ε4 homozygotes</article-title><source>Alzheimers Res Ther</source><year>2018</year><volume>10</volume><issue>1</issue><fpage>48</fpage><pub-id pub-id-type="doi">10.1186/s13195-018-0375-x</pub-id><pub-id pub-id-type="pmid">29793545</pub-id><pub-id pub-id-type="pmcid">PMC5968505</pub-id></element-citation></ref><ref id="CR52"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ludolph</surname><given-names>A</given-names></name><name name-style="western"><surname>Drory</surname><given-names>V</given-names></name><name name-style="western"><surname>Hardiman</surname><given-names>O</given-names></name><etal/></person-group><article-title>A revision of the El Escorial criteria - 2015</article-title><source>Amyotroph Lateral Scler Front Degener</source><year>2015</year><volume>16</volume><issue>5–6</issue><fpage>291</fpage><lpage>292</lpage><pub-id pub-id-type="doi">10.3109/21678421.2015.1049183</pub-id><pub-id pub-id-type="pmid">26121170</pub-id></element-citation></ref><ref id="CR53"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jenkinson</surname><given-names>M</given-names></name><name name-style="western"><surname>Beckmann</surname><given-names>CF</given-names></name><name name-style="western"><surname>Behrens</surname><given-names>TEJ</given-names></name><name name-style="western"><surname>Woolrich</surname><given-names>MW</given-names></name><name name-style="western"><surname>Smith</surname><given-names>SM</given-names></name></person-group><article-title>FSL</article-title><source>Neuroimage</source><year>2012</year><volume>62</volume><issue>2</issue><fpage>782</fpage><lpage>790</lpage><pub-id pub-id-type="doi">10.1016/j.neuroimage.2011.09.015</pub-id><pub-id pub-id-type="pmid">21979382</pub-id></element-citation></ref><ref id="CR54"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Douaud</surname><given-names>G</given-names></name><name name-style="western"><surname>Smith</surname><given-names>SM</given-names></name><name name-style="western"><surname>Jenkinson</surname><given-names>M</given-names></name><etal/></person-group><article-title>Anatomically related grey and white matter abnormalities in adolescent-onset schizophrenia</article-title><source>Brain</source><year>2007</year><volume>130</volume><issue>9</issue><fpage>2375</fpage><lpage>2386</lpage><pub-id pub-id-type="doi">10.1093/brain/awm184</pub-id><pub-id pub-id-type="pmid">17698497</pub-id></element-citation></ref><ref id="CR55"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Good</surname><given-names>CD</given-names></name><name name-style="western"><surname>Johnsrude</surname><given-names>IS</given-names></name><name name-style="western"><surname>Ashburner</surname><given-names>J</given-names></name><name name-style="western"><surname>Henson</surname><given-names>RNA</given-names></name><name name-style="western"><surname>Friston</surname><given-names>KJ</given-names></name><name name-style="western"><surname>Frackowiak</surname><given-names>RSJ</given-names></name></person-group><article-title>A Voxel-Based Morphometric Study of Ageing in 465 Normal Adult Human Brains</article-title><source>Neuroimage</source><year>2001</year><volume>14</volume><issue>1</issue><fpage>21</fpage><lpage>36</lpage><pub-id pub-id-type="doi">10.1006/nimg.2001.0786</pub-id><pub-id pub-id-type="pmid">11525331</pub-id></element-citation></ref><ref id="CR56"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Smith</surname><given-names>SM</given-names></name><name name-style="western"><surname>Jenkinson</surname><given-names>M</given-names></name><name name-style="western"><surname>Woolrich</surname><given-names>MW</given-names></name><etal/></person-group><article-title>Advances in functional and structural MR image analysis and implementation as FSL</article-title><source>Neuroimage.</source><year>2004</year><volume>23</volume><issue>Suppl 1</issue><fpage>S208</fpage><lpage>S219</lpage><pub-id pub-id-type="doi">10.1016/j.neuroimage.2004.07.051</pub-id><pub-id pub-id-type="pmid">15501092</pub-id></element-citation></ref><ref id="CR57"><label>57.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Anderson</surname><given-names>JLR</given-names></name><name name-style="western"><surname>Jenkinson</surname><given-names>M</given-names></name><name name-style="western"><surname>Smith</surname><given-names>SM</given-names></name></person-group><source>Non-linear registration aka Spatial normalisation. FMRIB Technical Report TR07JA2 [Internet]</source><year>2007</year><publisher-loc>Oxford</publisher-loc><publisher-name>FMRIB Centre</publisher-name></element-citation></ref><ref id="CR58"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Smith</surname><given-names>SM</given-names></name><name name-style="western"><surname>Jenkinson</surname><given-names>M</given-names></name><name name-style="western"><surname>Johansen-Berg</surname><given-names>H</given-names></name><etal/></person-group><article-title>Tract-based spatial statistics: Voxelwise analysis of multi-subject diffusion data</article-title><source>Neuroimage</source><year>2006</year><volume>31</volume><issue>4</issue><fpage>1487</fpage><lpage>1505</lpage><pub-id pub-id-type="doi">10.1016/j.neuroimage.2006.02.024</pub-id><pub-id pub-id-type="pmid">16624579</pub-id></element-citation></ref><ref id="CR59"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jenkinson</surname><given-names>M</given-names></name><name name-style="western"><surname>Bannister</surname><given-names>P</given-names></name><name name-style="western"><surname>Brady</surname><given-names>M</given-names></name><name name-style="western"><surname>Smith</surname><given-names>SM</given-names></name></person-group><article-title>Improved optimization for the robust and accurate linear registration and motion correction of brain images</article-title><source>Neuroimage</source><year>2002</year><volume>17</volume><issue>2</issue><fpage>825</fpage><lpage>841</lpage><pub-id pub-id-type="doi">10.1006/nimg.2002.1132</pub-id><pub-id pub-id-type="pmid">12377157</pub-id></element-citation></ref><ref id="CR60"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jenkinson</surname><given-names>M</given-names></name><name name-style="western"><surname>Smith</surname><given-names>SM</given-names></name></person-group><article-title>A global optimisation method for robust affine registration of brain images</article-title><source>Med Image Anal</source><year>2001</year><volume>5</volume><issue>2</issue><fpage>143</fpage><lpage>156</lpage><pub-id pub-id-type="doi">10.1016/S1361-8415(01)00036-6</pub-id><pub-id pub-id-type="pmid">11516708</pub-id></element-citation></ref><ref id="CR61"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Greve</surname><given-names>DN</given-names></name><name name-style="western"><surname>Fischl</surname><given-names>B</given-names></name></person-group><article-title>Accurate and Robust Brain Image Alignment using Boundary-based Registration</article-title><source>Neuroimage</source><year>2009</year><volume>48</volume><issue>1</issue><fpage>63</fpage><lpage>72</lpage><pub-id pub-id-type="doi">10.1016/j.neuroimage.2009.06.060</pub-id><pub-id pub-id-type="pmid">19573611</pub-id><pub-id pub-id-type="pmcid">PMC2733527</pub-id></element-citation></ref><ref id="CR62"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Griffanti</surname><given-names>L</given-names></name><name name-style="western"><surname>Salimi-Khorshidi</surname><given-names>G</given-names></name><name name-style="western"><surname>Beckmann</surname><given-names>CF</given-names></name><etal/></person-group><article-title>ICA-based artefact removal and accelerated fMRI acquisition for improved resting state network imaging</article-title><source>Neuroimage</source><year>2014</year><volume>95</volume><fpage>232</fpage><lpage>247</lpage><pub-id pub-id-type="doi">10.1016/j.neuroimage.2014.03.034</pub-id><pub-id pub-id-type="pmid">24657355</pub-id><pub-id pub-id-type="pmcid">PMC4154346</pub-id></element-citation></ref><ref id="CR63"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Salimi-Khorshidi</surname><given-names>G</given-names></name><name name-style="western"><surname>Douaud</surname><given-names>G</given-names></name><name name-style="western"><surname>Beckmann</surname><given-names>CF</given-names></name><name name-style="western"><surname>Glasser</surname><given-names>MF</given-names></name><name name-style="western"><surname>Griffanti</surname><given-names>L</given-names></name><name name-style="western"><surname>Smith</surname><given-names>SM</given-names></name></person-group><article-title>Automatic denoising of functional MRI data: Combining independent component analysis and hierarchical fusion of classifiers</article-title><source>Neuroimage</source><year>2014</year><volume>90</volume><fpage>449</fpage><lpage>468</lpage><pub-id pub-id-type="doi">10.1016/j.neuroimage.2013.11.046</pub-id><pub-id pub-id-type="pmid">24389422</pub-id><pub-id pub-id-type="pmcid">PMC4019210</pub-id></element-citation></ref><ref id="CR64"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Feis</surname><given-names>RA</given-names></name><name name-style="western"><surname>Smith</surname><given-names>SM</given-names></name><name name-style="western"><surname>Filippini</surname><given-names>N</given-names></name><etal/></person-group><article-title>ICA-based artifact removal diminishes scan site differences in multi-center resting-state fMRI</article-title><source>Front Neurosci</source><year>2015</year><volume>9</volume><fpage>395</fpage><pub-id pub-id-type="doi">10.3389/fnins.2015.00395</pub-id><pub-id pub-id-type="pmid">26578859</pub-id><pub-id pub-id-type="pmcid">PMC4621866</pub-id></element-citation></ref><ref id="CR65"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hyvärinen</surname><given-names>A</given-names></name></person-group><article-title>Fast and robust fixed-point algorithms for independent component analysis</article-title><source>IEEE Trans Neural Netw</source><year>1999</year><volume>10</volume><issue>3</issue><fpage>626</fpage><lpage>634</lpage><pub-id pub-id-type="doi">10.1109/72.761722</pub-id><pub-id pub-id-type="pmid">18252563</pub-id></element-citation></ref><ref id="CR66"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Beckmann</surname><given-names>CF</given-names></name><name name-style="western"><surname>Smith</surname><given-names>SM</given-names></name></person-group><article-title>Probabilistic independent component analysis for functional magnetic resonance imaging</article-title><source>IEEE Trans Med Imaging</source><year>2004</year><volume>23</volume><issue>2</issue><fpage>137</fpage><lpage>152</lpage><pub-id pub-id-type="doi">10.1109/TMI.2003.822821</pub-id><pub-id pub-id-type="pmid">14964560</pub-id></element-citation></ref><ref id="CR67"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Beckmann</surname><given-names>CF</given-names></name><name name-style="western"><surname>DeLuca</surname><given-names>M</given-names></name><name name-style="western"><surname>Devlin</surname><given-names>JT</given-names></name><name name-style="western"><surname>Smith</surname><given-names>SM</given-names></name></person-group><article-title>Investigations into resting-state connectivity using independent component analysis</article-title><source>Philos Trans R Soc B Biol Sci</source><year>2005</year><volume>360</volume><issue>1457</issue><fpage>1001</fpage><lpage>1013</lpage><pub-id pub-id-type="doi">10.1098/rstb.2005.1634</pub-id><pub-id pub-id-type="pmcid">PMC1854918</pub-id><pub-id pub-id-type="pmid">16087444</pub-id></element-citation></ref><ref id="CR68"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Damoiseaux</surname><given-names>JS</given-names></name><name name-style="western"><surname>Rombouts</surname><given-names>SARB</given-names></name><name name-style="western"><surname>Barkhof</surname><given-names>F</given-names></name><etal/></person-group><article-title>Consistent resting-state networks across healthy subjects</article-title><source>Proc Natl Acad Sci U S A</source><year>2006</year><volume>103</volume><issue>37</issue><fpage>13848</fpage><lpage>13853</lpage><pub-id pub-id-type="doi">10.1073/pnas.0601417103</pub-id><pub-id pub-id-type="pmid">16945915</pub-id><pub-id pub-id-type="pmcid">PMC1564249</pub-id></element-citation></ref><ref id="CR69"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rytty</surname><given-names>R</given-names></name><name name-style="western"><surname>Nikkinen</surname><given-names>J</given-names></name><name name-style="western"><surname>Paavola</surname><given-names>L</given-names></name><etal/></person-group><article-title>GroupICA dual regression analysis of resting state networks in a behavioral variant of frontotemporal dementia</article-title><source>Front Hum Neurosci</source><year>2013</year><volume>7</volume><fpage>461</fpage><pub-id pub-id-type="doi">10.3389/fnhum.2013.00461</pub-id><pub-id pub-id-type="pmid">23986673</pub-id><pub-id pub-id-type="pmcid">PMC3752460</pub-id></element-citation></ref><ref id="CR70"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tian</surname><given-names>L</given-names></name><name name-style="western"><surname>Kong</surname><given-names>Y</given-names></name><name name-style="western"><surname>Ren</surname><given-names>J</given-names></name><name name-style="western"><surname>Varoquaux</surname><given-names>G</given-names></name><name name-style="western"><surname>Zang</surname><given-names>Y-F</given-names></name><name name-style="western"><surname>Smith</surname><given-names>SM</given-names></name></person-group><article-title>Spatial vs. Temporal Features in ICA of Resting-State fMRI - A Quantitative and Qualitative Investigation in the Context of Response Inhibition</article-title><source>PLoS One</source><year>2013</year><volume>8</volume><issue>6</issue><fpage>e66572</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0066572</pub-id><pub-id pub-id-type="pmid">23825545</pub-id><pub-id pub-id-type="pmcid">PMC3688987</pub-id></element-citation></ref><ref id="CR71"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bey</surname><given-names>K</given-names></name><name name-style="western"><surname>Montag</surname><given-names>C</given-names></name><name name-style="western"><surname>Reuter</surname><given-names>M</given-names></name><name name-style="western"><surname>Weber</surname><given-names>B</given-names></name><name name-style="western"><surname>Markett</surname><given-names>S</given-names></name></person-group><article-title>Susceptibility to everyday cognitive failure is reflected in functional network interactions in the resting brain</article-title><source>Neuroimage</source><year>2015</year><volume>121</volume><fpage>1</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1016/j.neuroimage.2015.07.041</pub-id><pub-id pub-id-type="pmid">26210814</pub-id></element-citation></ref><ref id="CR72"><label>72.</label><mixed-citation publication-type="other">Beckmann CF, Mackay CE, Filippini N, Smith SM. Group comparison of resting-state FMRI data using multi-subject ICA and dual regression: OHBM; 2009.</mixed-citation></ref><ref id="CR73"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Winkler</surname><given-names>AM</given-names></name><name name-style="western"><surname>Ridgway</surname><given-names>GR</given-names></name><name name-style="western"><surname>Webster</surname><given-names>MA</given-names></name><name name-style="western"><surname>Smith</surname><given-names>SM</given-names></name><name name-style="western"><surname>Nichols</surname><given-names>TE</given-names></name></person-group><article-title>Permutation inference for the general linear model</article-title><source>Neuroimage</source><year>2014</year><volume>92</volume><fpage>381</fpage><lpage>397</lpage><pub-id pub-id-type="doi">10.1016/j.neuroimage.2014.01.060</pub-id><pub-id pub-id-type="pmid">24530839</pub-id><pub-id pub-id-type="pmcid">PMC4010955</pub-id></element-citation></ref><ref id="CR74"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gorgolewski</surname><given-names>KJ</given-names></name><name name-style="western"><surname>Varoquaux</surname><given-names>G</given-names></name><name name-style="western"><surname>Rivera</surname><given-names>G</given-names></name><etal/></person-group><article-title>NeuroVault.org: a web-based repository for collecting and sharing unthresholded statistical maps of the human brain</article-title><source>Front Neuroinform</source><year>2015</year><volume>9</volume><fpage>8</fpage><pub-id pub-id-type="doi">10.3389/fninf.2015.00008</pub-id><pub-id pub-id-type="pmid">25914639</pub-id><pub-id pub-id-type="pmcid">PMC4392315</pub-id></element-citation></ref><ref id="CR75"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cacciaglia</surname><given-names>R</given-names></name><name name-style="western"><surname>Molinuevo</surname><given-names>JL</given-names></name><name name-style="western"><surname>Falcón</surname><given-names>C</given-names></name><etal/></person-group><article-title>Effects of APOE-ε4 allele load on brain morphology in a cohort of middle-aged healthy individuals with enriched genetic risk for Alzheimer’s disease</article-title><source>Alzheimers Dement</source><year>2018</year><volume>14</volume><issue>7</issue><fpage>902</fpage><lpage>912</lpage><pub-id pub-id-type="doi">10.1016/j.jalz.2018.01.016</pub-id><pub-id pub-id-type="pmid">29605385</pub-id></element-citation></ref><ref id="CR76"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>ten Kate</surname><given-names>M</given-names></name><name name-style="western"><surname>Sanz-Arigita</surname><given-names>EJ</given-names></name><name name-style="western"><surname>Tijms</surname><given-names>BM</given-names></name><etal/></person-group><article-title>Impact of APOE-ɛ4 and family history of dementia on gray matter atrophy in cognitively healthy middle-aged adults</article-title><source>Neurobiol Aging</source><year>2016</year><volume>38</volume><fpage>14</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2015.10.018</pub-id><pub-id pub-id-type="pmid">26827639</pub-id></element-citation></ref><ref id="CR77"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>G</given-names></name><name name-style="western"><surname>Cox</surname><given-names>RW</given-names></name><name name-style="western"><surname>Glen</surname><given-names>DR</given-names></name><name name-style="western"><surname>Rajendra</surname><given-names>JK</given-names></name><name name-style="western"><surname>Reynolds</surname><given-names>RC</given-names></name><name name-style="western"><surname>Taylor</surname><given-names>PA</given-names></name></person-group><article-title>A tail of two sides: Artificially doubled false positive rates in neuroimaging due to the sidedness choice with t-tests</article-title><source>Hum Brain Mapp</source><year>2019</year><volume>40</volume><issue>3</issue><fpage>1037</fpage><lpage>1043</lpage><pub-id pub-id-type="doi">10.1002/hbm.24399</pub-id><pub-id pub-id-type="pmid">30265768</pub-id><pub-id pub-id-type="pmcid">PMC6328330</pub-id></element-citation></ref><ref id="CR78"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jiskoot</surname><given-names>LC</given-names></name><name name-style="western"><surname>Panman</surname><given-names>JL</given-names></name><name name-style="western"><surname>Meeter</surname><given-names>LHH</given-names></name><etal/></person-group><article-title>Longitudinal multimodal MRI as prognostic and diagnostic biomarker in presymptomatic familial frontotemporal dementia</article-title><source>Brain</source><year>2019</year><volume>142</volume><issue>1</issue><fpage>193</fpage><lpage>208</lpage><pub-id pub-id-type="doi">10.1093/brain/awy288</pub-id><pub-id pub-id-type="pmid">30508042</pub-id><pub-id pub-id-type="pmcid">PMC6308313</pub-id></element-citation></ref><ref id="CR79"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Feis</surname><given-names>RA</given-names></name><name name-style="western"><surname>Bouts</surname><given-names>MJRJ</given-names></name><name name-style="western"><surname>de Vos</surname><given-names>F</given-names></name><etal/></person-group><article-title>A multimodal MRI-based classification signature emerges just prior to symptom onset in frontotemporal dementia mutation carriers</article-title><source>J Neurol Neurosurg Psychiatry</source><year>2019</year><volume>90</volume><issue>11</issue><fpage>1207</fpage><lpage>1214</lpage><pub-id pub-id-type="doi">10.1136/jnnp-2019-320774</pub-id><pub-id pub-id-type="pmid">31203211</pub-id></element-citation></ref><ref id="CR80"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zuo</surname><given-names>X-N</given-names></name><name name-style="western"><surname>Kelly</surname><given-names>C</given-names></name><name name-style="western"><surname>Adelstein</surname><given-names>JS</given-names></name><name name-style="western"><surname>Klein</surname><given-names>DF</given-names></name><name name-style="western"><surname>Castellanos</surname><given-names>FX</given-names></name><name name-style="western"><surname>Milham</surname><given-names>MP</given-names></name></person-group><article-title>Reliable intrinsic connectivity networks: Test–retest evaluation using ICA and dual regression approach</article-title><source>Neuroimage</source><year>2010</year><volume>49</volume><issue>3</issue><fpage>2163</fpage><lpage>2177</lpage><pub-id pub-id-type="doi">10.1016/j.neuroimage.2009.10.080</pub-id><pub-id pub-id-type="pmid">19896537</pub-id><pub-id pub-id-type="pmcid">PMC2877508</pub-id></element-citation></ref><ref id="CR81"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zuo</surname><given-names>X-N</given-names></name><name name-style="western"><surname>Xing</surname><given-names>X-X</given-names></name></person-group><article-title>Test-retest reliabilities of resting-state FMRI measurements in human brain functional connectomics: A systems neuroscience perspective</article-title><source>Neurosci Biobehav Rev</source><year>2014</year><volume>45</volume><fpage>100</fpage><lpage>118</lpage><pub-id pub-id-type="doi">10.1016/j.neubiorev.2014.05.009</pub-id><pub-id pub-id-type="pmid">24875392</pub-id></element-citation></ref><ref id="CR82"><label>82.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>van Swieten</surname><given-names>JC</given-names></name><name name-style="western"><surname>Rosso</surname><given-names>SM</given-names></name><name name-style="western"><surname>Heutink</surname><given-names>P</given-names></name><etal/></person-group><person-group person-group-type="editor"><name name-style="western"><surname>Adam</surname><given-names>MP</given-names></name><name name-style="western"><surname>Ardinger</surname><given-names>HH</given-names></name><name name-style="western"><surname>Pagon</surname><given-names>RA</given-names></name><etal/></person-group><article-title>MAPT-Related Disorders</article-title><source>GeneReviews®</source><year>2000</year></element-citation></ref><ref id="CR83"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>van Swieten</surname><given-names>JC</given-names></name><name name-style="western"><surname>Heutink</surname><given-names>P</given-names></name></person-group><article-title>Mutations in progranulin (GRN) within the spectrum of clinical and pathological phenotypes of frontotemporal dementia</article-title><source>Lancet Neurol</source><year>2008</year><volume>7</volume><issue>10</issue><fpage>965</fpage><lpage>974</lpage><pub-id pub-id-type="doi">10.1016/S1474-4422(08)70194-7</pub-id><pub-id pub-id-type="pmid">18771956</pub-id></element-citation></ref><ref id="CR84"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Genin</surname><given-names>E</given-names></name><name name-style="western"><surname>Hannequin</surname><given-names>D</given-names></name><name name-style="western"><surname>Wallon</surname><given-names>D</given-names></name><etal/></person-group><article-title>APOE and Alzheimer disease: a major gene with semi-dominant inheritance</article-title><source>Mol Psychiatry</source><year>2011</year><volume>16</volume><issue>9</issue><fpage>903</fpage><lpage>907</lpage><pub-id pub-id-type="doi">10.1038/mp.2011.52</pub-id><pub-id pub-id-type="pmid">21556001</pub-id><pub-id pub-id-type="pmcid">PMC3162068</pub-id></element-citation></ref><ref id="CR85"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Eisenberg</surname><given-names>DTA</given-names></name><name name-style="western"><surname>Kuzawa</surname><given-names>CW</given-names></name><name name-style="western"><surname>Hayes</surname><given-names>MG</given-names></name></person-group><article-title>Worldwide allele frequencies of the human apolipoprotein E gene: Climate, local adaptations, and evolutionary history</article-title><source>Am J Phys Anthropol</source><year>2010</year><volume>143</volume><issue>1</issue><fpage>100</fpage><lpage>111</lpage><pub-id pub-id-type="doi">10.1002/ajpa.21298</pub-id><pub-id pub-id-type="pmid">20734437</pub-id></element-citation></ref></ref-list></back></article>